**Sponsored by Sideways Frequency, LLC

‍

Banzai has added users including Cisco, Hewlett Packard,Nextiva, Sprinklr, Globe Life Insurance, and LoanDepot

‍In total, this company now serves over 140,000 customers, making it clear that BNZI’s tech is in demand ‍

Total revenue for the nine months ended September 30, 2025, was $9.4 million, an increase of 190% compared to the prior year

‍This Company is Growing Revenue at Triple Digits While Slashing Losses!

CHECK OUT THE INVESTOR PRESENTATION HERE

_________________________

Hello Everyone,

Banzai International, Inc. (NASDAQ: BNZI) is emerging as a notable name in the Business Services space, backed by strong validation from Zacks Equity Research. The company currently holds a Zacks Rank #2 (Buy), a designation reserved for stocks with improving earnings outlooks and favorable near-term performance potential.

BNZI is part of the Business Services group, which includes 238 companies and currently ranks #12 out of 16 sectors under the Zacks Sector Rank framework—an indicator that the group is outperforming much of the broader market.

This sector-level strength adds another layer of support to BNZI’s bullish profile.

What truly sets BNZI apart is the sharp upward movement in earnings expectations. Over the last three months, the Zacks Consensus Estimate for the company’s full-year earnings has climbed an impressive 45.2%, reflecting rising analyst confidence and a strengthening fundamental outlook.

With a diverse customer base of more than 140,000 clients, including well-known enterprises such as Cisco, Hewlett Packard, New York Life, and Thermo Fisher Scientific, BNZI develops AI-powered marketing and business automation solutions that help companies attract, engage, and convert customers more efficiently. Its platform includes tools for video engagement, webinars, content creation, SEO, marketing automation, and AI-driven website and landing page generation through its Superblocks platform.

BNZI’s recent rating upgrade is therefore more than symbolic—it represents a measurable improvement in the company’s earnings power and positions the stock for potential upside as market participants respond to this positive shift.

They are quietly emerging as a powerhouse in the AI-driven marketing technology space, capturing the attention of enterprise giants like Cisco, Hewlett Packard, New York Life, and RBC Capital Markets.

BNZI is quietly building a powerhouse in one of the world’s fastest-growing industries—AI-driven marketing technology. While the market races to embrace AI in every facet of business, Banzai is already executing, expanding, and positioning itself as a frontrunner in delivering smart, scalable, and data-powered marketing solutions to over 90,000 customers and counting.


Why you should be paying very close attention:


Strategic Acquisitions Powering Massive Expansion. Banzai is growing not just organically but through strategic acquisitions designed to scale its technology stack, customer base, and recurring revenue with the completed acquisition of Vidello.

These deals aren’t just about buying growth—they’re about integrating high-demand, revenue-generating platforms that strengthen Banzai’s competitive advantage and expand its total addressable market across video, automation, and AI-driven outreach.

AI Innovation at the Core. AI isn’t a buzzword for Banzai—it’s the backbone of its products. From Curate, its new GPT-4o-powered newsletter builder that automates content marketing, to Demio, the company’s award-winning AI webinar platform, Banzai is proving that it can build and scale AI tools that drive real customer outcomes.


Its products are used by top names like Cisco, HP, Globe Life, New York Life, and dozens of others to power their marketing engines. Banzai’s tech is sticky, easy to deploy, and increasingly essential in a world that demands smart, automated engagement.


Real Steps Toward Profitability and Financial Strength. Few small caps can say they’ve improved net loss by millions of dollars in a single quarter, or repaid $20.3 million in liabilities ahead of schedule. Banzai did both. The company also improved its stockholders’ equity to a positive $2.4 million, giving it a healthier balance sheet and greater flexibility to fund future growth.


On top of that, management launched a cost-optimization strategy expected to boost net income by $13.5 million annually, extend cash runway, and maintain long-term scalability. This is operational discipline in action, not just another cash-burning tech startup.


Positioned in a $1.5 Trillion Industry with Explosive Tailwinds. The global digital marketing industry is exploding. It’s expected to reach $1.5 trillion by 2030, driven by rising demand for automation, video, analytics, and AI. Banzai’s product suite addresses all of these needs—precisely where the market is heading.


With nearly half of all businesses still lacking a digital marketing strategy—and billions of consumers moving online—Banzai is perfectly positioned to capture demand from underserved SMBs to massive enterprises.


A Founder-Led, Vision-Driven Company. Founder and CEO Joe Davy has shown a clear, data-backed vision for growth. Under his leadership, Banzai has:

• Exceeded revenue guidance,
• Delivered product innovation on time,
• Executed multiple acquisitions,
• Strengthened the balance sheet,
• And mapped a direct path to profitability.
  
  BNZI also announced a pivotal agreement with senior debt holder CP BF Lending, LLC (“Columbia Pacific”) that will eliminate approximately $4.8 million in senior secured debt. The payoff and conversion agreement — which includes both principal and accrued interest — will significantly strengthen Banzai’s balance sheet and enhance its financial flexibility. This milestone follows the company’s earlier repayment of $5.3 million in senior debt and underscores its ongoing commitment to reducing leverage and positioning for long-term, sustainable growth.

The company now serves over 140,000 customers, demonstrating that its AI-powered platforms—Curate for automated newsletters and Demio for high-conversion webinars—are driving real results. Strategic acquisitions like Vidello and OpenReel have added millions in revenue while bolstering the balance sheet, which now shows $3.2 million in positive stockholders’ equity, supported by an $11 million debt facility to fuel future growth.

BNZI is riding the broader AI wave and reshaping industries. Just as Nvidia is making headlines with massive investments in OpenAI, BNZI is applying AI innovation to the $1.5 trillion global marketing technology market—helping companies automate, engage, and scale more efficiently.

With a small-cap market value, a proven track record of triple-digit growth, and a rapidly expanding customer base, BNZI offers a rare opportunity to get in early on a company poised for breakout success. Whether through its AI-driven marketing tools or enterprise adoption strategy, BNZI is positioning itself to be a next-generation leader in MarTech and AI, making it a company hard to ignore.

This is a company that we have profiled many times in the past and have witnessed this one make several double digit moves.

BNZI is gaining serious momentum—and fast. While mega-cap names like Meta and Amazon dominate headlines, this under-the-radar marketing technology innovator is capturing the attention of industry titans like Cisco, Hewlett Packard, New York Life, and Globe Life.

With more than 140,000 customers, triple-digit revenue growth, and a growing suite of AI-powered solutions like Curate and Demio, Banzai is emerging as a serious contender in the race for MarTech dominance.

BNZI announced 2 massive acquisitions that are built to add revenues to the companies bottom line. We are talking about $44Million bucks here!

Banzai is a marketing technology company that provides essential marketing and sales solutions for businesses of all sizes. On a mission to help their customers achieve their mission, Banzai enables companies of all sizes to target, engage, and measure both new and existing customers more effectively. ‍

CATALYSTS

The LARGEST platform for finding software and services. More than 100 million people visit Capterra, GetApp, Software Advice, and UpCity across over 70 localized sites every year to read objective research and verified customer reviews that help them confidently choose the right software and services. Thousands of B2B companies work with Gartner Digital Markets to build their brand, capture buyer demand, and grow their business.

Banzai is a SaaS company building an AI-driven platform of essential MarTech data, analytics, and data-driven applications.Banzai is fueling marketing results with cutting-edge AI solutions.

SaaS company building an AI-driven platform of essential MarTech data,analytics, and data-driven applications

• While the global MarTech market is accelerating, marketers are struggling with an explosion of vendor complexity

• Banzai is fueling marketing results with an integrated platform of AI-PoweredMarTech solutions

• Reach deploys multi-channel outbound campaigns and is becoming the marketing automation AI demand gen platform standout• Demio provides transparent webinar insights for data-driven marketers with upstream updates launching in Q4

• Additional upside in strategic acquisitions with a substantial gap between current private vs. at-scale public market valuations.‍

Let’s take a look at some of the reasons we want BNZI on our screen:

‍
The company anticipates TRIPLING revenue with the acquisition of OpenReel. Banzai has recently signed a definitive agreement to acquire OpenReel, a digital video creation platform, in a stock deal valued at $19.6 million. OpenReel’s platform enables companies to create high-quality branded video content efficiently, serving enterprise customers including Bristol Myers Squibb, Ingram Micro, and DXC Technology. The acquisition will grow the company’s TTM revenue by 152% to $10.9M!

Strategic business initiatives to improve net income. Banzai announced $13.5M annual net income boost through cost-cutting initiatives and debt restructuring. Strategic cost-saving moves, including a 27% staffing reduction, aim to enhance scalability and extend cash runway.

A growing customer base and esteemed partnerships. Banzai saw the addition of 351 new customers in September-October 2024. The company also recently expanded partnerships with Salesforce and HubSpot.

The launch of Curate, a groundbreaking AI-driven newsletter solution. Curate is an AI-powered newsletter platform. Leveraging OpenAI’s GPT-4o, Curate automates the newsletter creation process by writing relevant, branded articles that resonate with target audiences. Curate then publishes content to a branded website and lets users set up daily or weekly updates, keeping their audience engaged with minimal effort and maximum impact.

Demio, the company’s AI-powered webinar platform, has been recognized with multiple accolades. Demio has been recognized by Gartner Digital Markets brands – Capterra, Software Advice, and GetApp.

Gartner Digital Markets is the world’s LARGEST platform for finding software and services. More than 100 million people visit Capterra, GetApp, Software Advice, and UpCity across over 70 localized sites every year to read objective research and verified customer reviews that help them confidently choose the right software and services. Thousands of B2B companies work with Gartner Digital Markets to build their brand, capture buyer demand, and grow their business.

Banzai Reports Third Quarter 2025 Financial Results

Revenue of $2.8 Million for Q3 2025, up 163% from Q3 2024

Gross Profit of $2.3 Million for Q3 2025, a 213% increase from Q3 2024; Gross Margin Expanded to 81.7% in Q3 2025, a 1,302 BPS Increase

Management to Host Third Quarter 2025 Results Conference Call Today, Friday, November 14, 2025 at 4:30 p.m. Eastern Time

SEATTLE, Nov. 14, 2025 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today reported financial results for the third quarter ended September 30, 2025.

Third Quarter 2025 and Subsequent Key Financial & Operational Highlights

• Revenue of $2.8 million for Q3 2025, representing an increase of 163% over Q3 2024.
• Gross profit of $2.3 million for Q3 2025, representing an increase of 213% over Q3 2024. Gross margin was 81.7% in Q3 2025, compared to 68.7% in Q3 2024.
• Annual Recurring Revenue (ARR) of $11.0 million for Q3 2025, representing a 168% increase in the same period year over year.
• Q3 2025 Net Loss was ($5.9) million, compared to ($15.4) million in Q3 2024.
• Q3 2025 Adjusted EBITDA was ($2.2) million, compared to ($1.5) million in Q3 2024.
• Cash balance was $0.9 million as of September 30, 2025.
• Stockholder’s Equity increased to $5.4 million as of September 30, 2025, an increase of $28.2 million, compared to September 30, 2024.
• Expanded customer base to over 140,000 total customers as of November 14, 2025.
• Acquired the assets of privately held Superblocks, an Agentic AI platform for developing and hosting launch-ready SEO-optimized websites.
• Executed a payoff and debt conversion agreement for the remaining principal balance of its outstanding senior secured debt, totaling approximately $4.8 million.
• Announced an institutional investor increased a direct equity stake to 18.7% following the exercise of warrants, demonstrating their continued confidence in Banzai’s long-term strategy.
• Appointed Matt McCurdy as Vice President of Sales to lead strategic growth and enterprise customer adoption of its AI-enabled marketing and sales solutions including Demio, CreateStudio, and OpenReel.
• Appointed Dean Ditto as Chief Financial Officer, bringing over 20 years’ experience as a strategic financial leader with a track record of implementing critical business initiatives that drive profitable growth at both public and private companies.
• Presented at investor conferences including the LD Micro Main Event XIX, Emerging Growth Conference, H.C. Wainwright 27th Annual Global Investment Conference.
• Secured an $11.0 million dollar debt facility with an institutional investor to support acquisitions and ongoing operations.

“The third quarter was highlighted the success of strategic priorities including revenue growth, a strengthened balance sheet combined with debt reduction, new leadership and an AI acquisition,” said Joe Davy, Founder and CEO of Banzai. “As we move into our next phase of growth, our Vidello and OpenReel businesses and strong performance for our products has validated our strategy with revenue of $2.8 million in the quarter, a 163% improvement from the prior year. Our growth was fueled by a strong focus on mid-market and enterprise customers, along with continued investment in the Reach product through re-engineering and enhanced sales initiatives. Altogether, we now serve more than 140,000 customers.

“Throughout 2025 we have made substantial improvements to our balance sheet and streamlined our cost structure, positioning the company for long-term, sustainable profitability. Most recently we executed a payoff and debt conversion agreement with a senior debt holder for the remaining principal balance of its outstanding senior secured debt, totaling approximately $4.8 million. The decision by senior debt holders to convert into equity reflects a strong vote of confidence in Banzai’s vision and trajectory. In September we paid off approximately $10.7 million of outstanding debt obligations year to date through August 31, 2025, and $32.7 million since September 2024. As we continued to execute on our repayments ahead of schedule, we have seen meaningful improvements to both net income and shareholders’ equity. Through the third quarter, we accomplished a $28.2 million year-over-year improvement in stockholders’ equity to a positive $5.4 million as of September 30, 2025. Also, in September we secured new debt financing of up to $11.0 million.

“In October, an institutional investor increased its direct equity stake to 18.7% following the exercise of warrants, another vote of confidence. We also implemented a strategic initiative that we expect will enable us to significantly improve net income, substantially extend our cash runway, and invest in growth. Taken together, we are making significant progress toward these goals and expect overall improvement in net income when fully implemented, while maintaining our growth outlook.

“We recently announced our newest acquisition of Superblocks, a platform that allows marketers to easily create and host websites, landing pages, and simple web applications using conversational AI. Building well designed, functional landing pages and websites have traditionally required teams to use rigid template-based site builders or possess extensive web development experience. Superblocks’ AI agent builds beautiful, brand compliant web assets quickly for businesses, marketers and creators. This acquisition advances our vision of building the AI platform for marketing and adds to our growing AI powered SaaS platform of solutions that make our customers’ lives 10x faster.

“Operationally, we strengthened our management team with the recent additions of Dean Ditto as Chief Financial Officer and Matt McCurdy as Vice President of Sales. Dean is a veteran financial and technology leader with strong capabilities in scaling public technology companies and driving profitable growth. Matt is an experienced executive and global sales leader with a proven track record of driving growth for over 20 years in the software, healthcare, and technology industries. He is now leading strategic growth and enterprise customer adoption of our AI-enabled marketing and sales solutions including Demio, CreateStudio, and OpenReel.

“Looking ahead, our strategic priorities include driving self-service subscriber growth, expanding within enterprise and mid-market segments, and improving customer retention, all while continuing to evolve our product portfolio. We are strategically investing in our software platform, sales and marketing, product innovation, acquisition strategy, and other organic growth opportunities with a disciplined approach to cost management. At the same time, we are fortifying our capital structure and balance sheet to fuel future growth and deliver lasting value to shareholders,” concluded Davy.

Third Quarter 2025 Financial Results

Banzai believes its non-GAAP financial measure ARR is more meaningful in evaluating its performance. The Company’s management team evaluates its financial and operating results utilizing this non-GAAP measure. For the three months ending September 30, 2025, ARR was $11 million, representing a 155.3% annualized ARR increase.

Total revenue for the three months ended September 30, 2025, was $2.8 million, an increase of 163% compared to the prior year quarter.

Total cost of revenue for the three months ended September 30, 2025, was $0.5 million, compared to $0.3 million in the prior year quarter, an increase of 54%. The increase was less than proportional to the revenue increase over the corresponding period, contributing to increased margins.

Gross profit for the three months ended September 30, 2025, was $2.3 million, compared to $0.7 million in the prior year quarter. Gross margin was 81.7% in the third quarter of 2025, compared to 68.7% in the third quarter of 2024.

Total operating expenses for the three months ended September 30, 2025, were $6.8 million, compared to $3.5 million in the prior year quarter. The increase in operating expenses were primarily due to the additions of OpenReel and Vidello and overall operating expenses.

Net loss for the three months ended September 30, 2025, was $5.9 million, compared to $15.4 million in the prior year quarter.

Adjusted EBITDA for the three months ending September 30, 2025, was ($2.2) million, compared to Adjusted EBITDA of ($1.5) million for the prior year quarter.

Nine Months 2025 Financial Results

Total revenue for the nine months ended September 30, 2025, was $9.4 million, an increase of 190% compared to the prior year period.

Total cost of revenue for the nine months ended September 30, 2025 was $1.7 million, compared to $1.0 million in the prior year quarter, an increase of 60%.

Gross profit for the nine months ended September 30, 2025, was $7.7 million, compared to $2.2 million in the prior year period. Gross margin was 82.0% in the first nine months of 2025, compared to 67.5% in the same period of 2024.

Total operating expenses for the nine months ended September 30, 2025, were $21.8 million, compared to $11.7 million in the prior year period. The increase in operating expenses were primarily due to the additions of OpenReel and Vidello and overall operating expenses.

Net loss for the nine months ended September 30, 2025, was $17.5 million, compared to $23.7 million in the prior year period.

Adjusted EBITDA for the nine months ended September 30, 2025, was ($5.6) million, compared to Adjusted EBITDA of ($4.8) million for the prior year period.

Net cash used in operating activities for the nine months ended September 30, 2025, was $13.4 million, compared to $5.4 million for the nine months ended September 30, 2024.

Cash totaled $0.9 million as of September 30, 2025, compared to $1.1 million as of December 31, 2024.

Annual Recurring Revenue (“ARR”) refers to annual run-rate revenue of subscription agreements from all customers in the last month of the measured period. These statements are forward-looking and actual ARR may differ materially. Refer to the “Forward-Looking Statements” section below for information on the factors that could cause Banzai’s actual ARR to differ materially from these forward-looking statements.

‍

Banzai Acquires AI Web Development and Hosting Platform Superblocks

Adds AI Agent for Building and Hosting Websites and Landing Pages to Banzai’s Growing Product Suite

SEATTLE, Nov. 10, 2025 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced it has acquired the assets of privately-held Superblocks, an Agentic AI platform for developing and hosting launch-ready SEO-optimized websites. The acquisition closed on November 7, 2025. Terms of the transaction were not disclosed.

The Superblocks platform allows marketers to easily create and host websites, landing pages, and simple web applications using conversational AI. Features include AI agent mode, design import from Figma or other visual mockups, and built-in hosting for targeted landing pages, e-commerce stores, blogs, chat apps, and portfolio sites. Using the platform’s AI Agent, users can describe what they want in natural language, and the AI agent then generates the user interface, functionality and deployment setup with modern frameworks like React, Vue, or Angular. Websites built with Superblocks are SEO optimized with built with search-engine best practices.

“This acquisition advances Banzai’s vision of building the AI platform for marketing. Building well designed, functional landing pages and websites have traditionally required teams to use rigid template-based site builders or possess extensive web development experience. Superblocks’ AI agent builds beautiful, brand compliant web assets quickly for businesses, marketers and creators,” said Joe Davy, Founder and CEO of Banzai. “Superblocks adds to our growing AI powered SaaS platform of solutions that make our customers’ lives 10x faster and easier. We believe Superblocks will become a powerful new AI tool for our customers.

“The future of marketing software depends on making the marketer’s job easier through AI and seamlessly integrated solutions. We are building beautifully designed products that leverage AI and automation to deliver results for customers that are faster and easier than ever before. Our growing family of tightly integrated best-in-class products includes webinars, video creation, marketing automation, and now websites and landing pages. This seamless integration and AI context create a moat of better product experience for customers and is helping marketers accomplish more in an AI empowered world,” Davy concluded.

About Superblocks

Superblocks is an online platform for building websites and landing pages using AI that is trusted by 1,000+ founders and creators. Features include AI agent mode, design import from Figma, and built-in hosting for targeted landing pages, e-commerce stores, blogs, chat apps, and portfolio sites. Using the platform’s AI Agent, users can describe what they want in natural language, and the AI agent then generates the user interface, functionality and deployment setup with modern frameworks like React, Vue, or Angular. Websites built with Superblocks are SEO optimized with built with search-engine best practices. For more information visit superblocks.xyz.

Q1 2025: More Revenue. Higher Margins. Lower Losses

In its Q1 2025 earnings, Banzai didn’t just deliver—it overdelivered:

• Q1 2025 revenue surged to $3.4 million, a 213% increase YoY and a 160% sequential jump over Q4 2024.
• Gross profit climbed to $2.8 million, a 297% year-over-year increase.
• Gross margin expanded to an impressive 82.1%, up from 64.7% in Q1 2024.
• Annual Recurring Revenue (ARR) hit $14.9 million, representing a 268% annualized growth rate over Q4 2024.
• Net loss improved by $4 million sequentially, dropping to ($3.6M) from ($7.9M) in Q4.
• Completed acquisition of Vidello on January 31, 2025.
• Successfully repaid $20.3 million in liabilities, ahead of schedule.
• Customer base expanded to over 90,000—a massive vote of confidence in the platform.

“In the first quarter, as our Vidello and OpenReel businesses continued to drive revenue momentum, we also focused on shoring up the financial strength of the company,” said Joe Davy, Founder and CEO of Banzai. “Revenue was $3.3 million for the first quarter of 2025, representing a 207% increase from the prior year from continued strong performance for our products.”

Let that sink in: TRIPLE DIGIT REVENUE GROWTH, soaring margins, declining losses, massive ARR acceleration, and an expanding customer base—all while managing capital effectively and reducing debt.

Banzai is executing with laser focus!

A Growth Engine Fueled by Smart Acquisitions

BNZI’s strategy is bold but strategic: acquire under-leveraged marketing tech platforms, integrate them under its brand, and scale them through cross-selling, AI upgrades, and deep product integrations. It’s working.

• Vidello and OpenReel, both acquired recently, have added $12.4 million in annual revenue.

And it’s not just about revenue. These acquisitions have helped Banzai boost stockholders’ equity by $5.1 million year-over-year, moving into positive territory at $2.4 million as of March 31, 2025. This is a company deleveraging, growing, and gaining momentum—all at the same time.

AI Innovation That Works: Curate & Demio

Banzai isn’t only growing by acquisition—it’s innovating from within:

• Curate, its AI-driven newsletter generator powered by OpenAI’s GPT-4o, automates content creation and audience engagement, revolutionizing how brands stay connected to customers.
• Demio, the company’s award-winning AI-powered webinar platform, is helping clients like Nutshell achieve 60% conversion rates and delivering 3x webinar ROI for companies like Tinuiti.

These products aren’t just clever—they’re sticky, scalable, and central to Banzai’s growing SaaS revenue.

Curate: The AI-newsletter that Writes and Grows Itself

Curate is the solution for busy professionals and brands who want to grow their audience effortlessly. Save hours on content creation, enjoy tailored newsletters, and watch your brand flourish.

‍

NEWS

Banzai Reports Third Quarter 2025 Financial Results

Nov 14, 2025

Banzai Acquires AI Web Development and Hosting Platform Superblocks

Nov 10, 2025

Banzai to Host Third Quarter 2025 Financial Results Conference Call on Friday, November 14, 2025 at 4:30 p.m. Eastern Time

Oct 30, 2025

Banzai Announces Agreement to Eliminate Senior Debt Through Payoff and Equity Conversion

Oct 17, 2025

Banzai International and Creighton University Discuss AI and Business Marketing

Oct 16, 2025

Banzai to Present at the LD Micro Main Event XIX Conference on Monday, October 20, 2025

Oct 14, 2025

Banzai Announces Institutional Investor Increases Direct Equity Stake to 18.7% Following Exercise of Warrants

Oct 14, 2025

Banzai to Present at the Emerging Growth Conference on Wednesday, September 24, 2025

Sep 17, 2025

Banzai Completes $32.7 Million Debt and Liability Elimination Through August 31, 2025

Sep 5, 2025

Banzai to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025

Sep 3, 2025

MANAGEMENT

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF TWENTY THOUSAND USD BY SIDEWAYS FREQUENCY LLC FOR A ONE DAY BNZI AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

**Sponsored by Knightscope, Inc.

U.S. Security Infrastructure Is Broken, Expensive, Fragmented, and Failing. This Silicon Valley Innovator Is Building the Nation’s First Autonomous Security Force to Fix It.

The $230 billion physical security market is stuck in a decades-old deadlock. No single provider has ever delivered automation and accountability under one roof. Until now.

‍‍Hello Everyone,

We have something new for you to research that operates in the consistently hot security sector. They are coming off of a huge 2025 adding over 8 figures to the top line with new contracts and some renewables. They expanded into some new sectors and things are starting to heat up for the company in a serious way.

Why is security relevant right now and what is the play in 2026?

Every few decades, an industry reaches a breaking point.

Costs spiral out of control. Performance falls apart. And no matter how much money gets thrown at the problem, nothing actually changes.

That moment has arrived for American security.

Right now, businesses are paying between $25 and $65 per hour for security guards. That adds up to $220,000 to $570,000 per year just to cover a single location around the clock.

Police departments spend $438,000 to $1.3 million per year for 24/7 coverage at a single post.

And what do they get for it?

Cameras sit unmonitored – out of the tens of millions of surveillance cameras across the US, less than 2% are watched live. Most security infrastructure isn’t even monitored. Guards, cameras, sensors, and software all operate in silos. No one owns accountability from end to end.

Security spending keeps rising. But safety outcomes keep falling behind.

The system isn’t just inefficient. It’s broken.

And the cost of that failure touches every corner of American life.

Here’s why this matters for investors right now.

The same forces that have driven every major tech disruption in history are now hitting a $230 billion market that has barely seen real innovation.

Today, America relies on roughly 800,000 sworn law enforcement officers and 1.3 million security guards to keep people safe.

All of it is human-centric. All of it is fragmented. All of it is reactive.

And hiring more people won’t fix it.

Technology alone can’t replace humans. But humans alone can’t scale. Cameras detect but don’t decide. Sensors alert but don’t respond. Most systems only get reviewed after something has already gone wrong. “You have a million cameras, and you are blind.”

The industry is stuck in a deadlock.

Security buyers don’t buy technology. They buy accountability. And for decades, no single company has been able to deliver both automation and end-to-end accountability under one roof.

Guard firms can’t scale. Tech-only vendors get disqualified from RFPs before they’re even evaluated. And the burden of sorting it all out always falls back on the client.

Until now.

A Silicon Valley security innovator publicly traded on Nasdaq, is building something that has never existed before.

The nation’s FIRST Autonomous Security Force.

A fully managed service that combines autonomous robots, AI-driven software, and augmented security agents into one integrated operation. A system that deters, detects, and responds to threats in real time. A platform that owns and manages outcomes for its clients, not just sells them another piece of a broken puzzle.

With approximately 10,000 machines already deployed nationwide, that company is Knightscope, Inc. (NASDAQ: KSCP).

And what is happening right now at Knightscope, Inc. (NASDAQ: KSCP) may represent one of the most compelling early-stage opportunities in the entire autonomous technology space.

Eight Consecutive monthly milestones exceeding $1 million in new sales. Twenty-four percent year-over-year revenue growth. A next-generation K7 product platform to begin deployment in the second half of 2026. And a newly retained acquisition advisor targeting cash-flowing security businesses as deployment channels for the Autonomous Security Force.

Knightscope, Inc. (NASDAQ: KSCP) is no longer building toward its inflection point.

It has arrived.

The World Is About to

Deploy Its First Autonomous Security Force

The shift has already started.

Autonomous machines are moving out of warehouses and factories and into the real world. AI is getting faster at detecting and responding to threats in real time. And the cost of deploying technology keeps falling while the cost of hiring humans keeps rising.

The direction of travel is clear.

The future of physical security will be built around more than one million autonomous machines supporting elite human teams. Always orchestrated. Always on. Never tired. Never distracted.

That is not a prediction. It is an inevitability.

The question for investors is not whether this shift is coming. It is who is going to lead it.

Because building the future of security is not as simple as deploying robots. The machines need to be connected. The data needs to be analyzed. Alerts need to be verified and acted on. And someone needs to own the outcome when something goes wrong.

That is a much harder problem to solve than most people realize.

It requires hardware, software, and humans working together as one integrated system.

Only one company in America is building all three under one roof.

Knightscope, Inc. (NASDAQ: KSCP) calls it the Autonomous Security Force. And it may be the most important development in physical security in a generation.

Meet the Company Building the Nation’s First Autonomous Security Force

Knightscope was founded in 2013 with a mission that has never changed.

To make the United States of America the safest country in the world.

That is not a marketing slogan. It is the foundation of every product the company builds, every contract it signs, and every machine it puts in the field.

Knightscope, Inc. (NASDAQ: KSCP) is a security technology innovator headquartered in Silicon Valley. It is building something that has never existed before in this country. A fully managed security service that uniquely combines autonomous robots, AI-driven software, and augmented security agents into one integrated operation.

Not a camera company. Not a guarding company. Not a software platform.

All three. Under one roof. Fully managed.

This is what Knightscope, Inc. (NASDAQ: KSCP) calls the Autonomous Security Force. And it is the only security solution in America that checks all six boxes that security buyers actually require.

‍Traditional guard firms can patrol and monitor. But they cannot scale and they cannot automate. Technology-only vendors can deploy robots. But they get disqualified from RFPs the moment a client asks who is accountable when something goes wrong.

Knightscope, Inc. (NASDAQ: KSCP) does not have that problem.

It plans to compete head to head with the largest guarding firms in the country. It wins RFPs that technology-only vendors cannot even enter. And it deploys its autonomous machines immediately across every contract it wins, replacing static human posts over time as the technology proves itself.

Guards are not the destination. They are the deployment catalyst for autonomy.

This is a deliberate strategy. And it is a smart one.

By entering the market as a full-service managed security provider, Knightscope, Inc. (NASDAQ: KSCP) gets a foot in the door at organizations that would never consider a technology-only vendor. Once inside, it begins replacing the most expensive and least effective parts of the security operation with autonomous machines.

The client gets better outcomes at lower cost. The company grows its recurring revenue. And the machines get smarter with every hour of deployment.

With approximately 10,000 machines already in network and deployments spanning healthcare, higher education, commercial real estate, manufacturing, retail, local government, and residential communities, the foundation is already in place.

Built in America. Designed to secure America.

8 Reasons Investors Are Paying Close Attention to Knightscope, Inc. (NASDAQ: KSCP) Right Now

1. A $230 Billion Market That Has Barely Been Touched Physical security is one of the largest and least disrupted industries in America. Knightscope, Inc. (NASDAQ: KSCP) is targeting an estimated $230 billion opportunity spanning government, healthcare, education, retail, critical infrastructure, and residential communities. That market is not going away. Security is a recurring societal problem that requires a recurring solution.

2. Revenue Growing 24% Year Over Year This is not a pre-revenue concept. Q3 2025 revenue came in at $3.1 million, up 24% from the same period a year earlier. Full-year 2025 revenue is estimated at $11 million. The growth is real and it is accelerating.

3. At Least Eight Consecutive Months of $1M+ in New Sales and Renewals Month after month, Knightscope, Inc. (NASDAQ: KSCP) has exceeded $1 million in new contracts, renewals, and expansions. That streak spans at least eight confirmed months running from April through December 2025, across healthcare, higher education, manufacturing, commercial real estate, local government, and more. In one standout month the company surpassed $2 million in a single reporting period. That is not a spike. That is a pattern.

4. The Only Provider That Checks All Six Boxes Licensed guarding. 24/7 monitoring. Autonomous patrol. Integrated response. Quality and consistency. Outcome accountability. Traditional guard firms check two. Technology-only vendors check one. No other company delivers all six.

5. Validated by One of the Most Respected Names in AI and Defense In 2025, Knightscope, Inc. (NASDAQ: KSCP) signed a two-year agreement with Palantir Technologies (NASDAQ: PLTR), joining Palantir’s FedStart program. Palantir does not partner with companies that are not ready to operate inside mission-critical environments. This agreement is a powerful signal of where Knightscope stands today.

6. A Next Generation Product Platform Deploying in 2026 The all-new K7 Autonomous Security Robot, K1 Capsule, and K1 Super Tower are all slated for limited release in the second half of 2026. All three are integrated with the all-new AI-driven Signals software platform and designed to unlock entirely new markets including critical infrastructure, logistics, and large outdoor environments.

7. A Smart Acquisition Strategy Already in Motion Knightscope, Inc. (NASDAQ: KSCP) has retained Lake Street Capital Markets as its exclusive buy-side advisor, targeting profitable, cash-flowing guarding companies as immediate deployment channels for the Autonomous Security Force. AI rewrites the economics of a legacy industry. This is how it scales fast.

8. A Leadership Team That Has Built and Scaled Before CEO William Santana Li is a former Ford Motor Company executive who co-founded GreenLeaf, which grew into the world’s second largest automotive recycler, now part of LKQ Corporation (NASDAQ: LKQ). The team around him brings decades of experience across finance, AI, design, and security operations. They have done this before. They are doing it again.

A Business Model Built to Compound Over Time

Most security companies sell a product and move on.

Knightscope, Inc. (NASDAQ: KSCP) built something different from day one.

Instead of selling robots, the company offers security as a fully managed service. This concept of a managed service provider has been proven to work in Information Technology (IT). Clients pay a recurring subscription fee and get autonomous machines, AI-driven software, and human oversight all bundled into one integrated operation. No large capital outlay. No fragmented vendors to manage. Just a single provider that owns the outcome.

This is the Machine-as-a-Service model (MaaS). And it is one of the most important structural advantages the company has.

Every machine deployed in the field generates predictable recurring revenue. Every renewal deepens the client relationship. Every new deployment expands the base. The longer a client stays, the more embedded the technology becomes. And the more embedded the technology becomes, the less likely a client is to leave.

Recurring revenue for a recurring societal problem.

But here is what makes the model even more compelling for investors.

The economics get better over time. Not just incrementally. Materially.

Knightscope, Inc. (NASDAQ: KSCP) has mapped out a clear three-phase path to margin expansion.

• In Phase 1, the company enters new contracts with a guard-heavy model. This generates immediate revenue and wins RFPs that technology-only vendors cannot even enter. The cash flow from guarding helps offset the cost of hardware investment.
• In Phase 2, autonomous machines begin replacing the most expensive static human posts within those same contracts. Revenue per site increases. The ratio of technology to human labor shifts. Margins begin to expand as software-driven services make up a larger share of the revenue mix.
• In Phase 3, robot density per site increases further. Operations become software-driven. Fewer humans are needed per contract. And margins expand materially.

The client gets better outcomes at lower cost over time. Knightscope, Inc. (NASDAQ: KSCP) gets a business that scales without a proportional increase in headcount.

That is not a common combination. And it is exactly what long-term investors look for.

With approximately 10,000 machines already in the network and at least eight consecutive months of $1 million or more in new sales and renewals, the foundation of that compounding model is already being built.

The machines are in the field. The subscriptions are renewing. And the path to margin is not theoretical.

It is already underway.

The Proof Is Already in the Field

Talk is cheap in the investment world.

What matters is execution and Knightscope, Inc. (NASDAQ: KSCP) has been delivering it consistently.

Here is what the numbers actually show.

Revenue Is Growing

In the third quarter of 2025, Knightscope, Inc. (NASDAQ: KSCP) reported $3.1 million in revenue, up 24% from the same period a year earlier.

Sales Momentum Has Become a Monthly Habit

Starting in April 2025 and running through December 2025, Knightscope, Inc. (NASDAQ: KSCP) has exceeded $1 million in new contracts, renewals, and expansions every single month. Eight consecutive months. Across healthcare, higher education, commercial real estate, manufacturing, solar facilities, local government, casinos, and residential communities.

The Balance Sheet Is Stronger Than It Has Ever Been

As of September 30, 2025, Knightscope, Inc. (NASDAQ: KSCP) held $20.4 million in cash, a $15.2 million improvement from the prior year. Year to date the company raised approximately $32.7 million through its at-the-market offering and direct registration transactions.

The leadership team has been direct about what that means for the road ahead. As Chairman and CEO William Santana Li stated following the Q3 2025 results:

“Our transition into our new headquarters has significantly strengthened our production capabilities and positioned us for greater operational efficiency as we prepare for our next phase of scaling.”

That next phase is already visible in the numbers.

Clients Are Diversified

The client base today spans nearly every major sector of the American economy. Healthcare networks expanding coverage across campuses. Universities are increasing deployments for student safety. Industrial manufacturers, casinos, solar facilities, semiconductor testing centers, and local governments all renewing subscriptions year after year.

That kind of diversification matters. It means no single sector can slow the company down. And the renewal rates across those verticals signal something even more important.

Once organizations deploy Knightscope, Inc. (NASDAQ: KSCP)’s technology, they tend to stay.

The Technology Behind the Autonomous Security Force

Most security companies sell you a piece of the puzzle.

A camera here. A software platform there. A guard company somewhere else.

Knightscope, Inc. (NASDAQ: KSCP) built the whole puzzle. Hardware, software, and humans working together as one fully integrated operation.

Here is what that looks like in practice.

Hardware: The Machines in the Field

The current fleet is already deployed and operational across the country.

The K5 Autonomous Security Robot is the workhorse of the existing fleet. It patrols indoor and outdoor environments around the clock, equipped with 360 degree perception, sensor fusion, and AI-driven anomaly detection. It deters, detects, and reports in real time without ever taking a break.

The K1 product family covers emergency communication. The K1 Blue Light Tower, K1 Call Box, and K1 Hemisphere are deployed across universities, hospitals, government facilities, transit hubs, and public spaces nationwide. These are not passive devices. They are active, connected nodes in a broader security network that feeds data back into the Knightscope platform in real time.

What Is Coming in the Second Half of 2026

The next generation of the platform is where things get significantly more exciting.

The all-new K7 Autonomous Security Robot is designed for large outdoor environments that traditional security systems simply cannot cover. Miles of fence lines. Logistics yards. Solar farms. Industrial complexes. Critical infrastructure. Defense installations.

The K7 combines light-duty off-road capability with Knightscope’s full suite of AI-powered detection, deterrence, and reporting technology. It can go where no camera and no human patrol can match.

The all-new K1 Capsule is a next generation emergency communication device designed to bring Knightscope’s connected safety network into environments that need a more compact and versatile form factor.

‍

The all-new K1 Super Tower takes the blue light concept to an entirely new level. A commanding, highly visible emergency communication presence designed for large open spaces, campuses, and critical facilities.

All three are integrated with the next generation Signals software platform and slated for limited production beginning in the second half of 2026.

Software: The Brain of the Operation

The Signals command and control platform is what ties everything together.

It fuses data from every machine in the network. It prioritizes alerts so human operators are not drowning in noise. It orchestrates escalation and response workflows through the use of AI agents. And it gets smarter with every hour of operation across every machine in the fleet.

This is not a passive monitoring dashboard. It is an active intelligence layer that turns thousands of data points into actionable security decisions in real time.

Humans: The Final Layer

Autonomous technology is powerful. But it is not infallible.

That is why Knightscope, Inc. (NASDAQ: KSCP) keeps humans in the loop by design.

The RTX remote monitoring team verifies events, manages edge cases, and executes escalation workflows around the clock. Augmented Security Agents (ASA) bring licensed guarding capability to every contract, allowing the company to compete for and win RFPs that technology-only vendors cannot touch.

Humans interpret ambiguity. Humans take accountability. And humans answer the phone at 3am when something goes wrong.

The machines handle the scale. The software handles the intelligence. And the humans handle the judgment.

Together, they are the Autonomous Security Force.

Two Engines Driving the Next Phase of Growth

Most companies have one way to grow.

Knightscope, Inc. (NASDAQ: KSCP) has two. And they are designed to work together.

Engine One: The New Technology Platform

The K1 product family, the K7 Autonomous Security Robot, and the Signals software platform represent the most significant product leap in the company’s history.

Together they form a scalable, repeatable autonomous security platform that can be deployed across multiple sites simultaneously, managed remotely, and improved continuously through AI and real-world operational data.

The economics of this platform are fundamentally different from anything the security industry has seen before.

As more machines go into the field, the software becomes more intelligent. As the software becomes more intelligent, fewer humans are needed per site. As fewer humans are needed per site, margins expand. And as margins expand, the company can deploy more machines faster.

Platform scale without proportional headcount growth.

That is the flywheel. And the K7 launch in the second half of 2026 is the moment it starts spinning faster.

The K7 opens markets that the current fleet simply cannot address. Critical infrastructure. Defense installations. Logistics yards. Solar and wind farms. Industrial complexes spanning thousands of acres. These are environments where human patrol is impractical, fixed cameras are insufficient, and the demand for autonomous coverage is growing rapidly.

Every new market the K7 unlocks is another layer of recurring revenue sitting on top of the existing base.

Engine Two: Strategic Acquisitions

The second growth engine is just as important. And it just got a major upgrade.

In February 2026, Knightscope, Inc. (NASDAQ: KSCP) retained Lake Street Capital Markets as its exclusive buy-side financial advisor. Their mandate is clear. Identify and acquire profitable, cash-flowing guarding businesses that can serve as immediate deployment channels for the Autonomous Security Force.

This is a brilliant strategic move for three reasons.

First, it solves the RFP problem instantly. Security contracts are written for licensed guarding providers with end-to-end accountability. By acquiring established guarding companies, Knightscope, Inc. (NASDAQ: KSCP) walks into those RFPs fully qualified from day one.

Second, it generates immediate revenue. These are not turnaround projects. The target acquisitions are profitable businesses with existing client bases and steady cash flow. They add revenue from the moment the deal closes.

Third, and most importantly, every acquired guarding company becomes a deployment channel for autonomous machines. Human guards become Augmented Security Agents. Static posts get replaced by robots over time. And the economics of the acquired business transform from a labor-heavy cost structure into a technology-driven margin expansion story.

As CEO William Santana Li put it:

“Our focus is on scaling Knightscope into the leading integrated security services platform.”

Guards are not the destination. They are the deployment catalyst for autonomy.

Two growth engines. One mission. And a strategy that gets more powerful the further it goes.

Knightscope, Inc. (NASDAQ: KSCP) is not waiting for the market to come to it.

It is going to get it.

How Does the Market Value Compare? The Numbers Tell a Striking Story.

One of the most powerful ways to evaluate any investment opportunity is to look at how the market values comparable companies in the same space.

When you line up Knightscope, Inc. (NASDAQ: KSCP) against its peers in the physical security and public safety technology sector, something immediately stands out.

Mission-critical communications and video security for public safety

Company

Ticker

Market Cap (Feb 13, 2026)

Description

Knightscope, Inc.

KSCP

~$41 Million

Autonomous Security Force. Robots, software, and human agents fully integrated.

Rekor Systems

REKR

~$112 Million

AI-driven roadway intelligence and public safety data

Evolv Technologies

EVLV

~$992 Million

AI-based weapons detection screening systems

NAPCO Security Technologies

NSSC

~$1.5 Billion

Electronic security systems, access control, and alarm technology

Axon Enterprise

AXON

~$34 Billion

Public safety technology. Body cameras, TASER, digital evidence management

Motorola Solutions

MSI

~$76.5 Billion

Mission-critical communications and video security for public safety

Market caps sourced from Yahoo Finance as of February 13, 2026.

The gap is significant. And the context makes it even more striking.

Evolv Technologies, a company that makes AI-based weapons detection screening systems, carries a market cap of nearly $1 billion. It does one thing. It detects weapons at entry points. It does not patrol. It does not respond. It does not own end-to-end accountability.

Knightscope, Inc. (NASDAQ: KSCP) does all of that and more, at a fraction of the valuation.

NAPCO Security Technologies, a maker of traditional alarm systems, access control, and door locks, carries a market cap of approximately $1.5 billion. Its products are largely passive. They alert. They do not act.

Axon Enterprise, widely considered the gold standard for public safety technology, has built a $34 billion business around body cameras, TASER devices, and digital evidence management software for law enforcement.

Knightscope, Inc. (NASDAQ: KSCP) is building the autonomous equivalent for physical security. A platform that patrols, detects, responds, and documents. In real time. Around the clock. Across every environment where people live, work, study, and visit.

With an estimated $11 million in 2025 revenue, a 24% year-over-year growth rate, and a next generation product platform set to unlock entirely new markets in the second half of 2026, the current market cap of approximately $41 million may not reflect where this company is headed.

The market has not yet caught up.

The Market Opportunity Is Almost Too Big to Ignore

Some markets are large. Some markets are growing. And some markets are both.

The physical security market is all of the above.

Knightscope, Inc. (NASDAQ: KSCP) is targeting an estimated $230 billion total addressable market. And it spans virtually every sector of the American economy.

Think about that number for a moment.

This is not a niche opportunity. This is not a single vertical or a single geography. This is a market that touches every place where people live, work, study, and visit. And security is not discretionary spending. It is a legal requirement, a liability concern, and a fundamental operational necessity for almost every organization in the country.

Recurring revenue for a recurring societal problem.

Here is how that $230 billion breaks down across the eight verticals Knightscope, Inc. (NASDAQ: KSCP) is actively targeting.

Public Safety and Government: $57 Billion Law enforcement agencies, correctional facilities, border security, military bases, and critical government infrastructure. This is the largest single vertical in the market and one where the demand for autonomous solutions is growing fastest.

Retail and Hospitality: $38 Billion Shopping malls, casinos, hotels, stadiums, event venues, and parking structures. These are high-traffic, high-visibility environments where deterrence matters as much as detection.

Critical Infrastructure: $37 Billion Energy and utilities, telecommunications, water and wastewater facilities, and seaports. These are exactly the kinds of large, remote, hard-to-patrol environments that the K7 was specifically designed to protect.

Enterprise: $34 Billion Corporate campuses, industrial and manufacturing facilities, logistics and warehousing, commercial real estate, and data centers. Many of these clients are already in the Knightscope network and renewing year after year.

Education: $21 Billion K-12 schools, colleges, universities, and research facilities. Campus safety has become one of the most urgent priorities in American public life and one of the strongest growth areas in the Knightscope portfolio.

Transit and Smart Cities: $20 Billion Airports, rail and transit hubs, parks, public spaces, and smart city surveillance networks. Urban environments where the scale of coverage required makes autonomous solutions not just attractive but essential.

Residential and Community Security: $18 Billion Apartments, condominiums, homeowner associations, gated communities, and mixed-use developments. One of the fastest-growing deployment verticals in the current Knightscope client base.

Healthcare: $7 Billion Hospitals and medical centers where around the clock security, emergency communication, and rapid response are not optional.

The Opportunity in Context

The infrastructure is built. The technology is proven. The client base is growing and diversifying. And the product pipeline launching in the second half of 2026 is designed to unlock markets the current fleet cannot yet reach.

The runway ahead is extraordinarily long.

The Team Behind the Mission

Great technology needs great leadership.

Knightscope, Inc. (NASDAQ: KSCP) is led by a team that has built, financed, and scaled complex operations before. They are not learning on the job. They are applying decades of hard-won experience to one of the most important problems in America today.

William Santana Li — Chairman and CEO William (“Bill”) Santana Li is the Chairman and CEO of Knightscope, Inc. (NASDAQ: KSCP), which he founded in 2013 after more than a decade at Ford Motor Company and leadership roles in automotive and security‑focused ventures including GreenLeaf LLC, later part of LKQ Corporation, and Carbon Motors Corporation, where he led development of a purpose‑built law‑enforcement vehicle, and he is focused on using advanced technology to help make the United States safer.

Apoorv S. Dwivedi — EVP and Chief Financial Officer Apoorv Dwivedi brings deep finance and corporate strategy experience from GE Finance, Cox Automotive, and Sears. He previously served as CFO of Nxu, Inc. during its Nasdaq listing in 2022. At Knightscope, Inc. (NASDAQ: KSCP) he oversees the financial discipline and capital strategy that has strengthened the balance sheet and positioned the company for its next phase of scaling.

Mercedes Soria — EVP and Chief Intelligence Officer / CISO Mercedes Soria is a technologist with over 15 years of experience in systems development, software architecture, and cybersecurity, including prior leadership roles in large consulting environments” unless you have a clear Deloitte-specific citation.

The Board of Directors

The board brings a rare combination of technology, defense, finance, and robotics expertise.

William G. Billings served as Vice President of Finance and Chief Accounting Officer at GlobalFoundries and held senior finance roles at Airbnb and General Electric, providing the financial oversight institutional investors expect.

Robert A. Mocny is a former Department of Homeland Security Senior Executive Service member who helped lead national biometric and border security programs after 9/11, giving Knightscope direct insight into federal security policy and procurement.

Melvin W. Torrie is the founder and CEO of Autonomous Solutions Inc., a global vehicle automation company serving industries from mining to agriculture with clients including NASA, Toyota, Komatsu, and Doosan, and his two decades in autonomy align closely with Knightscope’s mission.

This is not a team assembled for a press release. It is a team assembled to win.

The Window Is Open. But It Will Not Stay That Way.

Every major technology wave has a moment.

A moment when the technology is proven but the market has not fully caught on. When the revenue is real but the valuation has not caught up. When the early investors who pay close attention are rewarded and everyone else spends the next decade wishing they had.

This is that moment for physical AI and autonomous security.

Knightscope, Inc. (NASDAQ: KSCP) has spent more than a decade building toward this inflection point. The machines are in the field. The clients are renewing. The revenue is growing. The product pipeline is about to expand the addressable market significantly. And the acquisition strategy is designed to accelerate everything.

A market cap of approximately $41 million. A next generation platform launching in the second half of 2026.And a $230 billion total addressable market

The math speaks for itself.

Security is not going away. Crime is not going away. And the demand for smarter, faster, more accountable protection is only going to grow. Knightscope, Inc. (NASDAQ: KSCP) is the only company in America positioned to deliver all of it under one roof.

The infrastructure is built. The momentum is real. And the market is just beginning to wake up.

‍

NEWS

Knightscope Retains Lake Street to Support Growth Through Acquisitions

Feb 5, 2026

Knightscope Accelerates Past Another $1 Million in New Sales, Renewals & Expansions

Dec 17, 2025

Knightscope Unveils the All-New K7 Autonomous Security Robot

Nov 13, 2025

Knightscope Reports 24% YoY Revenue Growth for 3Q 2025

Nov 13, 2025

Knightscope Achieves Another $1 Million in New Sales and Renewals Expanding Recurring Revenue Base

Nov 12, 2025

Knightscope Surpasses Yet Another $1M Milestone in New Sales Won and Renewals

Oct 14, 2025

Knightscope Signs Another $1M in Renewals, Expansions and New Sales Won

Sep 4, 2025

Knightscope Reports Second Quarter 2025 Financial Results

Aug 13, 2025

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF FIFTEEN THOUSAND USD BY LFG EQUITIES CORP FOR A ONE DAY KSCP AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

**Sponsored by LFG Equities Corp and Disseminated on behalf of DevvStream

 DEVS: A pioneering environmental asset company listed on Nasdaq

DevvStream Corp and Fayafi Investment Holding Sign MOU to Explore Creation of “Fayafi x DevvStream Green Ventures” to Accelerate Global Sustainability Investments

XCF, IP3, Southern, and DevvStream Sign Non-Binding MOU to Evaluate America-First Nuclear Power for Clean Fuels Production and AI Data Centers

READ THE INVESTOR PRESENTATION HERE

_________________________

Hello Everyone,

We are profiling DevvStream today for you to research during today’s session.

You may want to add DEVS to your watchlist for further research.

DevvStream, XCF Global (Nasdaq: SAFX), and Southern Energy Renewables have entered into a binding term sheet dated January 26, 2026 regarding a proposed three-party business combination. Any transaction remains subject to the negotiation and execution of definitive agreements, required approvals, and other customary closing conditions.

If the deal goes through, the new combined company would bring several pieces of the clean-energy business under one roof — producing sustainable aviation fuel, generating carbon credits, and selling those environmental benefits to customers in the U.S. and other growing markets.

Their main goal is to speed up the production of low-carbon jet fuel using different technologies and to build more facilities in the United States. They also want to offer airlines and other customers a “one-stop shop” that includes both the physical fuel and the carbon credits that come with using cleaner energy.

As part of the discussions, they’re also looking at using small nuclear reactors to provide clean electricity for making synthetic jet fuel and for powering AI data centers, which could support additional environmental attributes and claims frameworks, subject to jurisdiction and program rules.

This development may expand DevvStream’s strategic opportunities in 2026, subject to execution. There are additional recent developments worth reviewing as you research DEVS.

• DevvStream has discussed a blockchain-based treasury and sustainability tokenization strategy that includes allocations to liquid digital assets that trade 24/7. The Company has described these assets as potentially usable as collateral and as part of a liquidity-focused treasury approach, subject to market volatility. The Company has indicated that this strategy is intended to support diversification of revenue sources and expand access to sustainability infrastructure, while potentially reducing reliance on traditional equity financing.
• The goal of that crypto treasury is to provide round-the-clock liquidity through Bitcoin, generate yield through Solana staking, and prepare for the tokenization of real-world assets such as renewable-energy facilities and sustainability infrastructure.
• The agreement with Energy Efficient Technologies could add two new revenue channels, expand the company into energy-efficiency assets, and further diversify both its income sources and customer base.
• Waste-to-energy projects in Indonesia give the company exposure to Southeast Asia, add revenue from I-RECs and carbon credits, and strengthen its position in a fast-growing regional market.
• The memorandum of understanding with Fayafi could lead to a global joint venture, allowing for large-scale climate investments, new income streams, and international expansion with limited upfront capital through a partnership structure.
• Some analyses citing ICAO/CORSIA estimates suggest airlines could require up to ~150 million credits during the 2024–2026 phase, depending on traffic growth and SAF use.
• In the shipping sector, the International Maritime Organization (IMO), a United Nations agency, has advanced a framework that would charge ships exceeding emissions thresholds, with pricing levels discussed around $100 per ton in certain proposals, alongside fuel-intensity standards and potential crediting mechanisms.
• DevvStream has built a sizable and diversified carbon-credit portfolio, positioning it to serve multiple industries that will need offsets.

‍

As stated above, DevvStream also signed a potentially significant Memorandum of Understanding with Fayafi Investment Holding — one of the UAE’s most forward-thinking investment platforms, to launch a global joint venture called Fayafi x DevvStream Green Ventures.

This joint venture would be backed by an initial funding commitment of $100 million and is built to deploy capital into climate infrastructure projects around the world, especially in fast-growing, underserved regions.

DevvStream will own 20% of the venture and serve as the operational and technical lead, with potential participation in revenue from environmental asset generation and investment returns. DEVS will be able to make money from both the environmental assets they generate and the returns from the investments through their percentage ownership of the JV.

With this structure, DevvStream gains direct access to the Middle East, a region that may have a need for carbon credits, thanks to the carbon-intensive nature of the oil and gas industry.

The combination of Fayafi’s institutional network and capital with DevvStream’s execution capabilities could create a scalable platform for environmental impact and value creation.

‍

Another major asset for DevvStream?

In 2024, DEVS acquired a 50% stake in the Monroe Sequestration Facility, one of the largest carbon storage facilities in N. America at 425 square miles with an estimated storage capacity of up to ~260 million metric tons of CO₂, subject to permitting, development, and verification. Potential economics may include benefits under Section 45Q (currently up to $85/ton for eligible sequestration), subject to qualification and compliance with IRS rules.

If you really want to understand DEVS you need to understand what carbon credits are. They are a financial tool designed to help organizations advance decarbonization efforts by funding environmentally conscious projects. Various industry reports estimate the global carbon market at approximately $1 trillion in size, with projections suggesting continued growth over the coming years, although forecasts vary.

In parallel with its operating initiatives, DevvStream launched a disciplined digital-asset treasury anchored in Bitcoin ($BTC) and Solana ($SOL), a diversified mix that combines institutional reserve strength, on-chain yield, and strategic exposure to real-world-asset (“RWA”) tokenization. Bitcoin provides a stable reserve foundation; Solana is currently earning staking rewards (on ≈ 12,185 SOL staked) at approximately 6.29% annualized yield, consistent with institutional benchmarks. In addition, DevvStream intends to acquire an allocation of DevvE ($DEVVE) and pursue additional blockchain initiatives to enhance the transparency and efficiency of environmental markets. These initiatives, developed in alignment with applicable registry terms and conditions, are intended to support the compliant digital representation of verified carbon credits and renewable energy certificates as transparent, tradable instruments.

Looking ahead, the Company anticipates that its tokenization platform will seamlessly interface with other RWA systems through standardized APIs, allowing project developers, auditors, and buyers to connect effortlessly, accelerating the mainstream adoption of tokenized sustainability assets.

The digital-asset program is intended to support liquidity and financing flexibility and may reduce—but does not eliminate—reliance on equity financing. The program is governed under an institutional framework developed with FRNT Financial and held in segregated custody at BitGo to support transparency and risk controls.

‍

The company is involved in a number of green initiatives with the ultimate goal of reducing the impact of climate change.

DEVS works with governments and corporations worldwide to achieve their sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air. DEVS also helps these organizations meet their net zero goals by providing them access to high-quality carbon credits.

What they do is  partner with companies that have technologies that are eligible for generating carbon credits, producing the credits on their behalf.  

DevvStream then gets 25% of the credits that are generated for the life of the project. This structure may allow DevvStream to participate in project economics without directly funding the underlying capital expenditures. 

______________

‍

‍

XCF, IP3, Southern, and DevvStream Sign Non-Binding MOU to Evaluate America-First Nuclear Power for Clean Fuels Production and AI Data Centers

• Potential to bring nuclear power, scalable eSAF production, and environmental-attribute monetization together into a single, integrated clean-energy platform.
• Exploring advancing next-generation eSAF pathways by pairing continuous clean electricity with electrolysis, hydrogen production, and low-carbon fuel synthesis.
• Evaluating high-integrity environmental-attribute structures that combine verifiable power, fuel, and digital MRV to unlock value for airlines and corporate decarbonization customers.

HOUSTON, TEXAS / ACCESS Newswire / December 30, 2025 / XCF Global, Inc. (“XCF”) (Nasdaq:SAFX) today announced a non-binding memorandum of understanding (“MOU”) to evaluate a strategic collaboration focused on small modular reactor (“SMR”) nuclear power, electro-sustainable aviation fuel (“eSAF”) production, and the creation, verification, and monetization of eligible environmental attributes alongside IP3 Corporation (“IP3”), Southern Energy Renewables Inc. (“Southern”), and DevvStream Corp. (“DevvStream”) (Nasdaq:DEVS) (together “the parties”).

The MOU outlines a proposed integrated framework to assess the deployment of firm, zero-carbon nuclear electricity from SMRs to support clean fuel production and energy-intensive end markets, including AI data centers, while enabling robust environmental-attribute structures that may meet evolving compliance, reporting, and market standards.

Chris Cooper, Chief Executive Officer of XCF Global, commented:

“This MOU reflects XCF’s disciplined approach to evaluating infrastructure and partnerships that can strengthen the scalability, reliability, and carbon performance of next-generation sustainable aviation fuels. Firm, zero-carbon power is an important enabler for eSAF pathways, and this collaboration allows us to assess how integrated power, fuel, and environmental-attribute frameworks could support broader adoption of clean fuels.”

The MOU contemplates the potential deployment of SMR-generated electricity to support existing and future operating assets, including a potential nuclear power solution for a proposed SAF and eSAF refinery in Louisiana, and to enable a scalable portfolio of verifiable environmental attributes.

Reliable, zero-carbon nuclear power is expected to enable continuous electrolysis, hydrogen production, and downstream fuel synthesis, while also supporting excess clean-power offtake for third-party customers where appropriate.

RDML (Ret.) Mike Hewitt, Chief Executive Officer of IP3, added:

“Clean, reliable nuclear power is increasingly being pursued as foundational infrastructure for American energy security and industrial growth. We are excited to explore a strategic relationship with XCF, DevvStream, and Southern, including the potential deployment of small modular reactor technology to provide firm power and support e‑SAF production for European markets.

“IP3’s business model to develop infrastructure projects to privatize Small Modular Reactors for multiple offtakers such as AI and data centers that support government and commercial requirements. We believe pairing firm power development with practical environmental‑asset design and monetization can create a differentiated platform that meets real customer demand while delivering the transparency the market expects.”

Although clean nuclear generation is generally not associated with traditional voluntary offset carbon credits, the parties believe nuclear-powered activity could support a range of environmental attributes and claims frameworks, subject to jurisdiction and program rules. These may include energy attribute certificates such as renewable energy certificates (“RECs”) or Guarantees of Origin, zero-emission credit frameworks and clean energy standards that recognize nuclear generation, and zero-carbon Scope 2 claims.

The parties also intend to evaluate environmental-attribute structures associated with eSAF and related low-carbon fuel pathways, including emerging “book-and-claim” and SAF certificate frameworks that allow airlines and corporate buyers to access verified in-sector emissions reduction attributes when physical fuel delivery is constrained.

Sunny Trinh, Chief Executive Officer of DevvStream, commented:

“Together, we are exploring real-world asset and tokenized environmental-asset frameworks with the potential to unlock additional value, improve liquidity, and help lower the delivered cost of clean energy and fuels. We see this as a potential America-first model that combines U.S. resources, digital infrastructure, and scalable markets.”

In parallel, the MOU contemplates future development of digital infrastructure to enhance transparency, provenance, and auditability, including tokenization of eligible environmental assets and the use of digital measurement, reporting, and verification (“MRV”) systems to support data quality, provenance, and auditability.

Jay Patel, Chief Executive Officer of Southern Energy, added:

“This MOU reflects our focus on putting American energy, infrastructure, and production first. As the development of advanced nuclear platforms gains momentum, we believe the goal of developing and deploying firm domestic power is becoming essential for fuels, manufacturing, and data-driven industries. We are committed to exploring how nuclear power, combined with U.S. biomass resources, can enable an integrated, multi-product approach that strengthens U.S. industrial leadership while remaining globally competitive.”

The MOU reflects a shared intent to collaborate on SAF and other low-carbon fuel opportunities. The MOU is non-binding and subject to the negotiation and execution of definitive agreements, of which there can be no assurances.

NEWS

Biomass-to-Jet SAF Projects Position Renewable Hydrocarbons as the Future of Aviation Fuel

Jan 28, 2026

DevvStream, Southern, and Frontline BioEnergy to Advance Biomass-to-Jet Development and Environmental-Asset Monetization

Jan 28, 2026

XCF Global, Southern Energy Renewables and DevvStream Agree to Binding Term Sheet for Three-Party Merger

Jan 26, 2026

XCF Global, Southern Energy Renewables and DevvStream Agree to Binding Term Sheet for Three-Party Merger

Jan 26, 2026

DevvStream to Present at the Emerging Growth Conference on January 21, 2026

Jan 15, 2026

Monetizing Sustainability: How Environmental Assets Are Driving Profitable Opportunities

Jan 14, 2026

DevvStream and Fayafi Execute Investment Agreement and Advance Plans for “Fayafi x DevvStream Investment Platform”

Jan 14, 2026

Zero-Carbon Nuclear Power Emerging as a Critical Pillar of the Clean Electricity Market Delivering a Scalable Growth Gateway

Dec 30, 2025

XCF, IP3, Southern, and DevvStream Sign Non-Binding MOU to Evaluate America-First Nuclear Power for Clean Fuels Production and AI Data Centers

Dec 30, 2025

DevvStream, Southern, IP3, and XCF to Evaluate Development of America-First Nuclear Power, Advanced Fuels, and Digital Environmental Asset Monetization

Dec 30, 2025

DevvStream Invites Shareholders to Virtual Annual Meeting Featuring Overview of Proposed Business Combination with Southern Energy Renewables

Dec 23, 2025

DevvStream, Southern Energy, and XCF Global Announce Plan to Pursue Strategic Collaboration to Build Integrated Low-Carbon Fuels Platform and Advance Multi-Pathway SAF Strategy

Dec 16, 2025

XCF Global, Southern Energy, and DevvStream Announce Plan to Pursue Strategic Collaboration to Build Integrated Low-Carbon Fuels Platform and Advance Multi-Pathway SAF Strategy

Dec 12, 2025

Louisiana Community Development Authority Authorizes up to $402 Million in Revenue Bonds for Southern Energy Renewables’ Louisiana Fuel Project

Dec 4, 2025

DevvStream and Southern Energy Renewables Announce Business Combination Targeting Low-Cost Production of Carbon-Negative SAF and Green Methanol

Dec 3, 2025

DevvStream Reports Fiscal Year 2025 Results and Advances Digital-Asset and Tokenization Strategy

Nov 6, 2025

‍

‍

MANAGEMENT

Sunny Trinh

CHIEF EXECUTIVE OFFICER

As co-founder and CEO, Sunny is responsible for building and executing DevvStream’s project pipeline through his vast network of sustainable technology and corporate relationships. He has spent over 25 years in the technology sector and directly in developing new verticals in ESG and carbon markets.

He also serves as the Chief Digital Alchemist for Devvio Inc., where he develops new business models in the ESG and carbon markets.  Prior to DevvStream, Sunny led innovation as VP of Ecosystem at Avnet Inc. (AVT: NASDAQ). He was also the COO for Jooster and VP of Sales for Arrow Electronics (ARW: NYSE) where he led the design team for a Corvette driven by a quadriplegic.

Sunny served as CEO for 9:Fish Surfboards and was an adjunct professor for Cal Lutheran University’s MBA program where he started the school’s technology tract. Sunny holds a B.S. and M.E in Engineering, an M.B.A. degree, and holds several patents on electronic accessories for cell phones.

David Goertz

CHIEF FINANCIAL OFFICER

David provides accounting, assurance, taxation and business advisory services to private and public companies, not-for-profit organizations and incorporated professionals. David has specialized knowledge of the manufacturing, mining, real estate, and technology industries. He also has a keen understanding of public company operations, restructurings, acquisitions and IPOs.

Chris Merkel

CHIEF OPERATING OFFICER

Chris is the VP and Chief Operating Officer of DevvStream. Prior to joining the team, Chris spent 24 years managing strategic customers, growing technical services verticals and held sales leadership roles at Avnet (AVT: NASDAQ) and Arrow Electronics (ARW: NYSE). He has engaged with companies at every stage, from pre-funded startups to global enterprises in markets such as IIoT, consumer, industrial and medical. Additionally, Chris spent 5 years with Sierra Pacific Industries in a general sales and operations management role. He has over 30 years of sales, operations and general management experience successfully managing diverse teams and projects.

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF TWENTY ONE THOUSAND FIVE HUNDRED USD BY LFG EQUITIES CORP FOR A ONE DAY DEVS AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

**Sponsored by LFG Equities Corp.

‍

GeoVax is stepping into 2026 with something it hasn’t had before: a clear, executable path to real commercial relevance.‍

READ THE INVESTOR PRESENTATION HERE

_________________________

Hello Everyone,

We have a new company that just experienced several events that make it extremely important that we put this one on your radar immediately.

Pull up GeoVax Labs (NASDAQ: GOVX) right away.

GeoVax is stepping into 2026 with something it hasn’t had before: a clear, executable path to real commercial relevance. After years of platform building, the story is no longer theoretical — the company now has a defined late-stage program, manufacturing ready to scale, and multiple clinical readouts that could reshape how the market values the pipeline. The centerpiece is its Mpox/smallpox vaccine, which quietly received regulatory alignment in Europe for a single pivotal Phase 3 immunobridging study — a faster, cheaper, and far less risky route to approval than a traditional efficacy trial. In a world where governments are actively trying to secure domestic vaccine supply and reduce reliance on a single overseas producer, that positioning matters. Layer on top the potential for U.S.-based continuous manufacturing, fresh Phase 2 data in its next-generation COVID program targeting immunocompromised patients, and the move to push Gedeptin into a checkpoint-inhibitor combination study in oncology, and you get a company transitioning from “science project” to “catalyst cycle.”

The next twelve months aren’t about promises — they’re about execution: trial initiations, data, partnerships, and funding decisions that will determine whether this becomes a procurement-driven revenue story or just another development-stage biotech. For the first time, the pieces are lining up at the same time, and that convergence is what makes this GOVX genuinely worth watching as we kick off 2026.

There are several recent events that make GOVX enticing to research right now. We know that timing is everything in the markets whether its Gold, BTC, Commodities or equities. We are looking this one as it is just coming off of a restructuring which dramatically reduced the float on GOVX. Finviz has it under 1.75 Million right now.

They also just announced the successful completion of fill-finish for the initial clinical batch of GEO-MVA, its next-generation Mpox/smallpox vaccine. The product has now entered final release evaluation, the concluding quality-control and compliance process required before shipment for clinical use, positioning the Company for Phase 3 immunobridging trial start-up activities in Q1 2026.

Clinical and Regulatory Milestone

Fill-finish – the sterile, cGMP-regulated process of filling, sealing, and packaging vaccine vials – marks the last manufacturing step before a vaccine may enter clinical study supply channels. With fill-finish complete and GEO-MVA now undergoing final release evaluation, GeoVax has moved into the final pre-clinical-deployment phase of its EMA-aligned clinical program.

In June 2025, the European Medicines Agency (EMA) Scientific Advice confirmed that a single Phase 3 immunobridging study demonstrating immune comparability to the approved MVA vaccine, Imvanex®, would be sufficient to evaluate GEO-MVA’s efficacy. This provides a clear, accelerated regulatory path to licensure.

This milestone coincides with increasing Mpox activity globally – including expanding Clade I outbreaks in Africa and emerging cases in the United States – exposing vulnerabilities associated with global dependence on a sole foreign MVA vaccine supplier. GEO-MVA is designed to expand supply, diversify sources, and strengthen biodefense infrastructure.

The clinical-stage biotechnology company developing novel vaccines for many of the world’s most threatening infectious diseases and therapies for solid tumor cancers. The company’s lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. A Phase 2 clinical trial in first recurrent head and neck cancer, evaluating Gedeptin® combined with an immune checkpoint inhibitor is planned to initiate during the first half of 2025. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades.

The market is massive and the prospects are enormous.

Recently, Bavarian Nordic, a European vaccine maker of Mpox and Small Pox vaccines was offered $3B in a private equity buyout offer, which looks to be moving forward. In 2024, their MVA vaccine program generated $462M in revenue. This is not suggesting GeoVax will get a $3B buyout also, but is definitely indicative of the large potential of the market GeoVax is addressing and the strong interest from large industry players/investors.

https://www.reuters.com/business/healthcare-pharmaceuticals/nordic-capital-permira-make-3-billion-offer-vaccine-maker-bavarian-nordic-2025-07-28

GeoVax’s GEO-MVA candidate leverages a proprietary MVA vector to address the Mpox crisis and the ongoing threat of smallpox, offering broad protection, scalability, and resilience in vaccine supply. Unlike Bavarian Nordic, GeoVax is based in the U.S. and has invested heavily in a continuous cell line manufacturing process that supports large-scale, rapid, and cost-efficient production—an upgrade over traditional egg-based methods. This positions GeoVax to supply not only domestic needs but also bolster global pandemic preparedness and biosecurity, as recognized by recent favorable regulatory guidance from the European Medicines Agency (EMA) permitting a fast-tracked pathway to approval.

GeoVax Announces Issuance of U.S. Patent Covering Enhanced Therapeutic Use of Gedeptin(R) Gene Therapy

Patent Protects Novel Application of Gedeptin Therapy Across Multiple Solid Tumor Types; Supports Expansion of Gedeptin Product Platform

ATLANTA, GA – December 9, 2025 (NEWMEDIAWIRE) – GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies against cancers and infectious diseases, today announced the issuance of U.S. Patent No. 12,453,760, titled “Enhanced Therapeutic Usage of a Purine Nucleoside Phosphorylase or Nucleoside Hydrolase Prodrug”, by the United States Patent and Trademark Office (USPTO). The patent provides composition-of-matter and method-of-use protection for GeoVax’s Gedeptin® platform in combination with targeted delivery approaches for solid tumors, including head and neck cancer.

The newly issued patent, which extends through 2045, enhances the Company’s intellectual property estate for Gedeptin and its use across a range of solid tumor cancers – consolidating GeoVax’s leadership in the field of targeted gene therapies and supporting ongoing clinical development plans.

“The issuance of this patent marks an important milestone in the advancement and protection of GeoVax’s oncology pipeline,” said David A. Dodd, Chairman and Chief Executive Officer of GeoVax. “It underscores our commitment to progressing Gedeptin, both as a monotherapy and in synergistic combination with other oncology treatment approaches as we work to deliver meaningful treatment options for patients with difficult-to-treat solid tumors.”

The Company is actively preparing for a Phase 2 clinical trial evaluating Gedeptin as a first-line therapy in combination with pembrolizumab (Keytruda®) in resectable head and neck cancer, in line with the recent shift toward neoadjuvant checkpoint strategies. Additional preclinical programs are assessing Gedeptin across other tumor types, including breast and cutaneous cancers.

About Gedeptin®

Gedeptin is a gene-directed enzyme prodrug therapy (GDEPT) designed for targeted use in solid tumors. Delivered via a non-replicating adenoviral vector encoding purine nucleoside phosphorylase (PNP) and followed by systemic fludarabine, Gedeptin generates localized cytotoxic activity within tumors while minimizing systemic toxicity. The therapy has demonstrated safety and disease control in a multi-center Phase 1/2 trial in patients with advanced head and neck cancer and has received FDA Orphan Drug Designation for oral and pharyngeal cancers.

GeoVax plans to advance Gedeptin into a Phase 2 trial in combination with pembrolizumab (Keytruda®) as a neoadjuvant regimen for resectable head and neck squamous cell carcinoma, supported by recent clinical data validating the role of immune checkpoint inhibitors in perioperative settings. Additional preclinical work is underway to assess Gedeptin combinations across other solid tumors.

Key Advantages of Gedeptin

• Localized, tumor-selective cytotoxicity
• Tumor agnostic – expansion potential across multiple solid tumors
• Synergistic potential with checkpoint inhibitors
• Favorable safety profile and orphan drug designation
• Strong patent protection through 2045

‍

GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients

DSMB Ends Comparator Arm; Trial Proceeds Exclusively With GEO-CM04S1 Following mRNA Vaccine’s Failure to Meet Primary Endpoint

Phase 2 Data Reinforce GEO-CM04S1 as an Important Next-generation Vaccine Candidate for the 40 Million U.S. and 400 Million Global Immunocompromised Patients Underserved by First-generation COVID-19 Vaccines

ATLANTA, GA – December 15, 2025 (NEWMEDIAWIRE) – GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today announced the publication of interim Phase 2 clinical data on its next-generation COVID-19 vaccine in patients with chronic lymphocytic leukemia (CLL).  

The Research Letter in the British Journal of Haematology reports that GEO-CM04S1 met the study’s primary immunologic endpoint, generating significantly stronger and more durable SARS-CoV-2-specific T-cell responses than BNT162b2 (Pfizer-BioNTech) in patients with chronic lymphocytic leukemia (CLL) – a population known for poor vaccine responsiveness.

Importantly, following interim analysis, the trial’s Data and Safety Monitoring Board (DSMB) ruled to discontinue the randomized, double-blind comparator arm after the mRNA vaccine failed to meet the predefined primary immunogenicity endpoint. Enrollment is now proceeding exclusively in a single-arm cohort receiving GEO-CM04S1, as previously described in GeoVax’s clinical update at the European Hematology Association (EHA) 2025 Conference.

GEO-CM04S1’s superior performance in enhancing cellular immune response against SARS-CoV-2 in individuals with CLL, a patient population that generally responds sub optimally to vaccines designed to induce humoral (antibody) responses, underscores its potential to fill a protection gap for profoundly immunocompromised patients. More than 40 million adults in the U.S. and 400 million globally have some degree of compromised immunity, many of whom fail to mount meaningful responses to currently authorized COVID-19 vaccines. GEO-CM04S1 is specifically designed to address this gap through its dual-antigen (Spike + Nucleocapsid), MVA-based platform, which promotes robust, durable T-cell responses that are less impacted by immune dysfunction and viral variation.

Phase 2 Study Overview (NCT05672355)

• CLL patients previously vaccinated with mRNA vaccines
• 31 enrolled; 27 evaluable for primary analysis
• Primary endpoint: greater than or equal to 3-fold rise in antigen-specific IFN-y-secreting T cells at Day 56
• Assessments: T-cell responses, binding/neutralizing antibodies, safety
• No Grade greater than or equal to 3 adverse events reported

Key Findings Published in BJH

1. GEO-CM04S1 achieved superior T-cell responses

• 40% of GEO-CM04S1 recipients met the primary endpoint vs. 14.3% for BNT162b2
• Higher Spike-specific IFN-y responses at Days 28, 56, and 84

2. Durable activation of Nucleocapsid-specific T cells

• Approximately 10-fold higher N-specific CD4 T-cell activation vs. BNT162b2
• Responses maintained through Day 180

3. Broader immune engagement in spite of CLL-associated humoral defects

• GEO-CM04S1 generated sustained N-IgG and a correlation between N-specific antibodies and T-cell activation
• mRNA vaccination produced higher early RBD-IgG titers but limited cellular immunity

Kelly T. McKee, MD, MPH, Chief Medical Officer, stated: “These results demonstrate GEO-CM04S1’s ability to address the immune limitations of CLL patients by inducing strong, durable T-cell responses to both spike and nucleocapsid proteins of SARS-CoV-2. The DSMB’s decision to discontinue the comparator arm further validates the vaccine’s clinical relevance for immunocompromised individuals.”

David Dodd, Chairman & CEO, added: “With more than 40 million immunocompromised Americans, many of whom lack durable protection from first-generation vaccines, GEO-CM04S1 represents a purpose-built solution for high-risk patients. This peer-reviewed publication strengthens our regulatory and partnering strategy as we advance toward potential commercialization.”

Medical and Commercial Significance

The findings published in BJH, combined with the DSMB’s action, reinforce the value of the differentiated profile of GEO-CM04S1 across multiple dimensions:

1. Critical unmet need: Immunocompromised individuals remain vulnerable and, in many cases, sub optimally protected from the threat of SARS-CoV-2.
2. Multi-antigen design: GEO-CM04S1’s dual-antigen design stimulates immune responses that appear to be more durable and variant-resilient than single-antigen mRNA approaches.
3. These segments represent a $30B+ annual potential commercial market.

About GEO-CM04S1

GEO-CM04S1 is a dual-antigen MVA-vectored COVID-19 vaccine being evaluated in multiple Phase 2 trials, including a primary vaccination for immunocompromised individuals, and a booster vaccination for CLL patients.

The vaccine has generated robust immune responses in difficult-to-vaccinate populations including CAR-T and stem-cell transplant recipients, who typically fail to respond well to first-generation vaccines.

‍

MVA TECHNOLOGY OVERVIEW

GeoVax’s vaccines are constructed to induce broader immunity through inclusion of multiple antigens into a single virus/vaccine platform. This is possible through the use of the company’s MVA vaccine platform, a large virus capable of incorporating multiple antigens into a vaccine platform.

Utilizing MVA, as a vaccine vector, allows for the targeting of multiple sites on a pathogen or cancer cell. Doing this is intended to result in a more robust and durable protective immune response. In addition, using MVA as a vaccine platform allows for the construction of vaccines which are capable of generating virus-like particles (VLPs) in the person receiving the vaccine.

The production of VLPs in the person being vaccinated is intended to mimic viral production that occurs in a natural infection, stimulating both the humoral (antibody) and cellular (T-cell) arms of the immune system to recognize, prevent, and control future infections.

MVA vectored vaccines can elicit durable (long-acting) immune responses while also possessing an excellent safety profile. MVA-VLP vaccines are designed to mimic authentic viruses in form but are not infectious or capable of replicating. As a result, VLPs can cause the body’s immune system to recognize and kill targeted infectious agents to prevent an infection or can be designed to target cancerous cells resulting in inhibited growth or destruction of tumors. VLPs can also train the immune system to recognize and kill virus-infected cells to control infection and reduce the length and severity of disease.

GEDEPTIN TECHNOLOGY OVERVIEW

A Phase 1/2 trial (NCT03754933), evaluating the safety and efficacy of repeat cycles of Gedeptin therapy in patients with recurrent head and neck squamous cell carcinoma (HNSCC), with tumor(s) accessible for injection and no curable treatment options recently completed enrollment at the Stanford University Cancer Institute, the Emory University Winship Cancer Institute, and the Thomas Jefferson University Sidney Kimmel Cancer Center.

The trial design involved repeat administration using Gedeptin followed by systemic fludarabine (prodrug). Expansion towards a larger, Phase 2 patient trial is anticipated. The FDA has granted Gedeptin orphan drug status for the intra-tumoral treatment of anatomically accessible oral and pharyngeal cancers, including cancers of the lip, tongue, gum, floor of mouth, salivary gland and other oral cavities. Also, the initial Phase 1/2 clinical study was funded by the FDA pursuant to its Orphan Products Clinical Trials Grants Program.

‍

NEWS

GeoVax Labs Announces $1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

1 hour ago

GeoVax Highlights 2026 as a Pivotal Year for Progress

Jan 20, 2026

GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement

Jan 8, 2026

GeoVax Labs, Inc. to Review Progress and Strategic Priorities During Biotech Showcase 2026 and J.P. Morgan Healthcare Conference Week

Jan 6, 2026

GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering

Dec 19, 2025

GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Using the Multi-Antigen GEO-CM04S1 Vaccine

Dec 18, 2025

GeoVax Receives Formal EMA Scientific Advice Supporting Pivotal Phase 3 Immunobridging Trial for GEO-MVA

Dec 18, 2025

GeoVax Announces Completion of GEO-MVA Fill-Finish, Supporting Phase 3 Immunobridging Clinical Trial Start-Up in Early 2026

Dec 17, 2025

GeoVax Receives U.S. Patent Office Notice of Allowance for Broad-Spectrum COVID-19 Vaccine Design

Dec 16, 2025

GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients

Dec 15, 2025

GeoVax Addresses Identification of New Mpox Variant

Dec 11, 2025

GeoVax Announces Addition of Renowned Global Experts to Its Scientific Advisory Board

Dec 10, 2025

GeoVax Announces Issuance of U.S. Patent Covering Enhanced Therapeutic Use of Gedeptin(R) Gene Therapy

Dec 9, 2025

GeoVax Announces JCO Oncology Advances Publication Highlighting Favorable Safety and Evidence of Disease Stability of Gedeptin(R) in Recurrent Head & Neck Cancer

Dec 8, 2025

GeoVax to Present at the Noble Capital Markets Twenty-First Annual Emerging Growth Equity Conference

Nov 24, 2025

GeoVax Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 13, 2025

GeoVax Recognizes World Immunization Day: Advancing Innovation and Trust in Vaccination

Nov 10, 2025

GeoVax Recognizes World Immunization Day: Advancing Innovation and Trust in Vaccination

Nov 10, 2025

GeoVax to Report Third Quarter 2025 Financial Results and Provide Corporate Update on November 13, 2025

Nov 4, 2025

GeoVax Announces Relocation of Corporate Headquarters and Laboratory Operations to Support Accelerated Growth and Pipeline Advancement

Nov 3, 2025

‍

MANAGEMENT

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF FIFTEEN THOUSAND USD BY LFG EQUITIES CORP FOR A ONE DAY GOVX AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

**Sponsored by Interactive Offers, LLC

Healthcare Triangle Subsidiary QuantumNexis Reports $20M in Consumption-Based Revenue Processed on Ezovion Platform, Forecasts $37M Amid Rapid Growth

Healthcare Triangle, Inc. Signs Advance Agreement for the Acquisition of Next-Generation AI Customer Engagement Business, on track to generate $34M in Revenue for FY 2025

A fast-moving company at the center of healthcare’s cloud and AI transformation — backed by real contracts, real margins, and real momentum

__________________________________

Hello Everyone,

We have a time sensitive situation that we want you to be aware of ahead of today’s session. I say “time sensitive” because the company had a major even that JUST took place. Get HCTI on your screen before you do anything else.

The company just effected a reverse stock split that reduced the Company’s number of shares outstanding from approximately 45,417,091 all the way down to approximately 756,952 shares. We often see companies take a hit when word gets out and we just saw HCTI down for 9 sessions in a row but the bleeding appears to have slowed down.

Finviz says there are 180k shares in the float. Even if that is close to accurate we are dealing with a nano-float.

HCTI is no stranger to going on strong runs in the past and with the companies new structure in place and those looking at this one right now are in the forefront with the ink barely dry on last weeks announcement that foretold of Tuesday’s split.

HCTI is already generating substantial revenues and if you take peak at the companies newsfeed you will see that the pot is about to get a little bit sweeter in the future with numberThe healthcare system is undergoing one of the most disruptive technology shifts in history, and Healthcare Triangle (NASDAQ: HCTI) is rapidly aligning itself with where the industry is headed.

Hospitals and providers are racing to deploy AI to eliminate inefficiencies, automate workflows, and improve patient outcomes — and HCTI’s AI-first strategy places it directly in that demand stream.

Through its QuantumNexis platform, HITRUST-certified cloud solutions, and expanding SaaS offerings, HCTI is transitioning toward higher-margin, recurring revenue at a time when global healthcare AI adoption is accelerating sharply.

Zacks Small Cap Research has taken notice, emphasizing that HCTI is well positioned to benefit as providers increasingly turn to AI to drive operational efficiency.

That thesis gained real weight with HCTI’s planned acquisition of Teyame.AI, a fast-growing AI engagement company expected to deliver $34 million in annual revenue. Teyame’s agentic generative AI, multilingual chatbot automation, and omnichannel engagement capabilities — already proven in regulated industries and piloting in healthcare — could instantly elevate HCTI into a global digital health engagement leader.

Combined with HCTI’s existing hospital intelligence, EHR, and mental health platforms, this move expands total addressable market, accelerates international growth, and positions HCTI for a potential step-change in scale — all while analysts’ revenue forecasts have yet to include any contribution from the deal.

Healthcare Triangle, Inc., based in Pleasanton, California, drives digital transformation for healthcare and life sciences organizations through advanced cloud, data, and AI solutions. The company serves hospitals, health systems, payers, and pharmaceutical/life sciences enterprises with technology designed to enhance clinical efficiency and operational performance.

By helping organizations improve health outcomes through optimized use of data and information technologies, Healthcare Triangle plays a critical role in digital transformation across the healthcare ecosystem. The company’s Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™, has achieved HITRUST Risk-based, 2-year (r2) Certified status—an industry-recognized benchmark for data protection and information security.

Healthcare Triangle enables the adoption of emerging technologies, supports data-driven decision-making, and facilitates agility in response to business demands and market pressures. With the addition of QuantumNexis, the company has further expanded its reach into AI-powered SaaS solutions that support mental health, hospital automation, and intelligent clinical workflows.

With a focus on compliance, interoperability, and emerging technologies, Healthcare Triangle remains a trusted partner for highly regulated healthcare and life sciences sectors worldwide.

Healthcare Triangle is entering its next phase of growth with clear momentum across its AI-driven SaaS platforms and growing opportunities in both the U.S. and international markets. Together, the EHR, healthcare cloud, and AI segments represent a combined $128B+ market opportunity, creating a robust backdrop for HCTI’s long-term growth potential.

QuantumNexis has already processed about $20 million in revenue through the Ezovion platform, with visibility toward $37 million in the near term—giving investors an early look at the platform’s scaling potential.

The U.S. launch of Ziloy, Ezovion’s inclusion on the Microsoft Azure Marketplace, and new global partnerships are broadening reach and strengthening confidence in future revenue.

Alongside new health-system contract wins, the expansion of HCTI’s AI-powered EHR services, and a strategic pipeline that now includes a non-binding LOI to acquire Teyame.AI, the company is setting the stage for more scalable, recurring, and diversified revenue growth ahead.

Why Look at HCTI Right Now

Strategic Expansion into Gen AI Healthcare SaaS: Healthcare Triangle, Inc. has launched a dedicated AI subsidiary, aligning with high-growth generative AI applications in healthcare.

Exposure to Multi-Trillion Dollar Market Trends: Active in segments projected to exceed $2.3 trillion by 2034, including digital health, AI, cloud computing, and analytics.

HITRUST Certified Platforms: CloudEz™ and DataEz™ platforms are HITRUST r2 certified, demonstrating strong data protection and compliance standards.

Recent Strategic Acquisitions: Acquisitions of Niyama and Ezovion strengthen capabilities in mental health SaaS and hospital intelligence systems.

Strong Customer Traction: Solutions deployed in over 325 hospitals across Asia and MEA, supporting proven scalability.

‍Recurring Revenue Model: Growing shift toward SaaS-based offerings supports predictable, high-margin revenue streams.

Global Partnership Ecosystem: Collaborations with AWS, Microsoft Azure, Google Cloud, and other major platforms enhance technological reach and reliability.

Focused Cost Optimization Plan: Ongoing enterprise-wide initiative targeting $1.8 million in annualized savings to improve operational efficiency.

Healthy Balance Sheet: HCTI holds more cash than total debt, reflecting a prudent financial structure and lower leverage risk.

Positioned for Global Digital Health Demand: With expansion into Southeast Asia and beyond, HCTI is aligned with rising international demand for digital healthcare modernization.

Healthcare Triangle Inc. subsidiary QuantumNexis Announce Joint Venture with Golden Code Holdings to Accelerate AI and Digital Health Transformation in Saudi Arabia

This Joint Venture strengthens Healthcare Triangle’s and QuantumNexis’ position to access the fastest growing Saudi Arabia 70-billion-dollar Healthcare Market by 2030

PLEASANTON, Calif., Feb. 5, 2026 /PRNewswire/ — Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industries, today announced that its subsidiary QuantumNexis is participating a Joint Venture with Golden Code Holdings to address the 70 Billion US dollar Healthcare Market by 2030 and align with the Saudi Arabian Kingdom’s rapidly advancing healthcare transformation agenda.

This Joint Venture brings together QuantumNexis’ global expertise in AI‑powered healthcare platforms and open standards with Golden Code Holdings’ strong local presence, investment capability, and deep understanding of the Saudi market. It will play a pivotal role in supporting Saudi Vision 2030, the Ministry of Health’s digital strategy, and the Kingdom’s ambition to build a world‑leading, interoperable, and data‑driven healthcare ecosystem and shifting towards value-based care, focusing on patient outcomes rather than volume.

Driving National‑Scale Digital Health Modernization

The QuantumNexis Team will introduce a unified suite of advanced digital health platforms in Saudi Arabia, including:

• Ezovion — a next‑generation hospital and clinical operations platform
• Ziloy.ai — AI‑powered clinical and operational intelligence
• Readabl.ai — automation and documentation intelligence for care teams
• openEHR ‑ based interoperability solutions through global partnerships with Better.care and Microsoft.

These solutions will support hospitals, clinics, and enterprise healthcare groups in modernizing workflows, improving care coordination, and enabling real‑time insights across the continuum of care.

Aligned with Saudi Arabia’s Vision 2030

The Joint Venture is designed to advance key national priorities by:

• Deploying open standards and interoperable platforms across health systems
• Enabling AI‑driven decision support, predictive analytics, and operational optimization
• Building a Saudi‑based digital health workforce through capability development programs
• Supporting localization, compliance, and long‑term sustainability
• Establishing a regional hub for innovation, research, and co‑development

David Ayanoglou, Chief Financial Officer of HCTI said, “We are excited to be part of this large project which will have aim to have large impacts on patient outcomes and will proliferate the deployment of our offerings in the region”.

Kathir K., President & Chief Growth Officer, QuantumNexis, said, “Our joint venture with Golden Code Holdings marks a defining moment in our global expansion. Saudi Arabia is shaping the future of healthcare, and together we are building a standards‑driven, AI‑powered ecosystem that empowers providers, strengthens national capabilities, and delivers measurable outcomes for patients across the Kingdom.”

Mustafa Razza, Director of Growth, Golden Code Holdings, added, “Partnering with QuantumNexis and HCTI aligns with our commitment to bring world‑class digital health innovation to Saudi Arabia. This joint venture will accelerate the Kingdom’s transition to interoperable, data‑driven healthcare and create new opportunities for local talent and technology leadership.”

A Regional Hub for Digital Health Innovation

QuantumNexis presence in Saudi Arabia will serve as the company’s Middle East hub, supporting:

• Government health programs
• Private hospital groups
• Enterprise healthcare networks
• Academic and research collaborations
• Workforce development initiatives

The Joint Venture will also drive co‑innovation with global partners to bring advanced AI, automation, and interoperability solutions to the region.

About Healthcare TriangleHealthcare Triangle, Inc. based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare organizations including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes through better utilization of the data and information technologies that they rely on. Healthcare Triangle achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical & business performance optimization.

About Quantum Nexis

Quantum Nexis is a global digital health ecosystem focused on AI‑powered platforms, interoperability, and healthcare modernization. Through its multi‑brand portfolio and strategic partnerships, the company supports hospitals, clinics, and health systems across Asia, the Middle East, Africa, and Europe.

About Golden Code Holdings

Golden Code Holdings is a Saudi‑based technology and investment group with deep expertise in digital transformation, enterprise solutions, and national‑scale technology programs. The company partners with global innovators to bring advanced solutions to the Kingdom.

MANAGEMENT

• Dave Rosa
• Chairman of the Board
• Dave Rosa is the Chairman of the Board of Directors; and is a member of our Board of Directors since August 2021. He is also the President and CEO of NeuroOne Medical Technologies, a publicly traded company. He also serves on the boards of Biotricity a publicly traded company. Mr. Rosa has over 25 years of experience in holding a variety of senior management roles across several medical device markets.

‍

• Ronald McClurg
• Member of the Board
• Mr. McClurg has over 30 years of financial leadership experience with public and private companies. Mr. McClurg has served as CFO of NeuroOne Medical Technologies Corp. (Nasdaq: NMTC) since January 2021. Prior to joining NeuroOne, from 2003 to 2019, Mr. McClurg served as VP – Finance and CFO of Incisive Surgical, Inc. Prior to 2003, Mr. McClurg served as CFO of Wavecrest Corporation, Video Sentry Corporation, Insignia Systems, Inc. (Nasdaq: ISIG), and Orthomet, Inc. Currently, he serves on the board of governors of Biomagnetic Sciences, LLC and serves as a director and audit committee chair for Biotricity, Inc. (Nasdaq: BTCY).

• Jainal Bhuiyan
• Member of the Board
• Jainal is currently a Senior Managing Director in investment banking at Paulson Investment Company. Prior to Paulson, he was a partner at HRA Capital, a boutique investment bank he co-founded in 2012 . Over the course of his 18 years of healthcare investment banking and capital markets experience, he has advised private and public healthcare companies from start-ups to commercially mature enterprises, totaling more than $3B in transactions. He holds FINRA Series 7, Series 63, and Series 79 licenses.

‍

• Sujatha Ramesh
• Chief Operating Officer & Board Director
• Sujatha Ramesh is the Chief Operating Officer and Board Director of Healthcare Triangle Inc., where she leads operational strategy, sales, customer success, delivery, HR, governance, and financial planning. She also serves as the Chief Operating Officer of HCTI’s subsidiary company, providing hands-on leadership in scaling operations and delivery. Sujatha plays a key role in mergers and acquisitions, supporting strategic growth and integration initiatives.
• With over 25 years of global leadership experience in financial services and technology, she has led enterprise-wide transformations across the Americas, Europe, and Asia. Sujatha brings deep expertise in operational strategy, corporate growth, technology modernization, regulatory compliance, and risk management. She has managed budgets exceeding $250 million and delivered over $112 million in value through strategic transformation and operational efficiency.
• She previously held senior roles at Citigroup, Publicis Sapient, Infinite Computer Solutions, and Capgemini (iGATE Global Solutions).
• Sujatha brings a powerful combination of operational expertise, governance insight, strategic foresight, and global execution excellence to HCTI’s boardroom—further strengthening the Company’s leadership as it drives global expansion and transformation.

‍

‍

NEWS

Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split as Part of Nasdaq Compliance Plan

5 days ago

Healthcare Triangle Inc. subsidiary QuantumNexis Announce Joint Venture with Golden Code Holdings to Accelerate AI and Digital Health Transformation in Saudi Arabia

6 days ago

Healthcare Triangle Inc. Partners with Better.care to Expand Health Data Platform Services Across EMEA’s Leading Healthcare Systems

Jan 29, 2026

Healthcare Triangle, Inc. Announces Participation and Presentation at the Deal Flow Discovery Conference in Atlantic City

Jan 28, 2026

DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week’s Event

Jan 23, 2026

Healthcare Triangle, Inc. Signs Definitive Agreement with Teyame AI LLC which is forecasted to generate $38M in incremental NTM Revenue and incremental NTM EBITDA of $5M in addition to expanding its SaaS Footprint in Europe and Latin America

Jan 22, 2026

Healthcare Triangle, Inc. Signs Advance Agreement for the Acquisition of Next-Generation AI Customer Engagement Business, on track to generate $34M in Revenue for FY 2025

Dec 10, 2025

Spartan Capital Securities, LLC Serves as Sales Agent in Healthcare Triangle, Inc.’s $20 Million At-the-Market Offering

Nov 24, 2025

Healthcare Triangle’s Strategic Intent Rewarded with a 32% Share Gain Since September (NASDAQ:HCTI)

Oct 14, 2025

Healthcare Triangle Plays Offense to Redefine What Aggressive Growth Looks Like (NASDAQ: HCTI)

Oct 13, 2025

Healthcare Triangle Executes Aggressive Growth Strategy, Announcing Within One Week Both $34 Million Planned Acquisition Revenue and Processing of $20 Million in Revenue Generated by Healthcare Providers on Ezovion Platform

Oct 10, 2025

Healthcare Triangle, a $16M Microcap, Targets Teyame.AI and Its $34M FY2025 (NASDAQ: HCTI)

Oct 10, 2025

Healthcare Triangle Takes Bold Step toward AI-Driven Future with the Signing of a Non-Binding LOI for the Acquisition of Teyame.AI, which is on track to generate $34M in Revenue for fiscal year 2025 and would create for Healthcare Triangle a Next-Gene…

Oct 9, 2025

WallachBeth Capital Announces Healthcare Triangle Warrant Inducement For Aggregate Gross Proceeds Of $478,000

Oct 8, 2025

Healthcare Triangle Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $478,000

Oct 8, 2025

Healthcare Triangle Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $478,000

Oct 8, 2025

WallachBeth Capital Announces Healthcare Triangle Warrant Inducement For Aggregate Gross Proceeds Of $755,000

Oct 3, 2025

Healthcare Triangle Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $755,000

Oct 3, 2025

Healthcare Triangle Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $755,000

Oct 3, 2025

UPDATE: Healthcare Triangle Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $1.63 Million

Oct 2, 2025

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF FIFTEEN THOUSAND USD BY INTERACTIVE OFFERS LLC FOR A ONE DAY HCTI AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

**Sponsored by Spark Newswire Inc

‍

VisionWave’s Counter-UAS Systems Featured by a U.S. Tier-1 Defense Partner at Association of the United States Army – AUSA 2025

VisionWave is advancing next-generation defense and AI autonomy through live-fire proven technologies, Tier-1 collaborations, and strategic partnerships across the U.S., UAE, and India — positioning itself at the forefront of intelligent defense innovation

_______________________

Hello Everyone,

Our last alert traded up over 10% off of the open this morning and closed up over 6%.

We are brining back a past winner that we first took a look at back in August when it was sitting around below the current levels of 9.42. Back then it was sitting in the 8’s before it went on to make 52 week highs of 15.80.

Pull up VWAV right away for today’s session.

VisionWave Holdings is an early-stage defense technology company focused on AI-powered autonomous systems, advanced RF (radio frequency) sensing and imaging, radar platforms, vision systems, counter-drone solutions (such as Argus), unmanned ground vehicles, active protection systems, and computational acceleration technologies. The company serves military, homeland security, and critical infrastructure markets across air, land, and maritime domains. Founded in 2024 and taken public via SPAC in 2025, VisionWave is assembling a platform of proprietary technologies — supported by more than 50 patents — aimed at enabling real-time threat detection, edge-based AI decision-making, and autonomous operations in highly complex environments.

VWAV’s is positioned at the intersection of two of the most powerful themes in global markets: defense and artificial intelligence. This convergence is especially compelling because modern warfare increasingly depends on systems that can sense, decide, and respond faster than adversaries in contested environments where legacy sensors and human-in-the-loop processes are too slow or vulnerable.

Why AI + Defense Is One of the Most Compelling Growth Areas

Rising geopolitical tensions and rapidly evolving threats — including drone swarms, electronic warfare, and non-line-of-sight attacks — are driving elevated and sustained defense spending. The U.S. defense budget is approaching $900 billion, while key subsegments are expanding quickly: aerospace AI is projected to approach $30 billion in 2026, electronic warfare around $20 billion, and broader military AI applications are forecast to exceed $35 billion by 2034. Autonomous and counter-drone “autonomous shield” technologies represent tens of billions more in potential addressable markets.

Artificial intelligence is reshaping defense by enabling edge computing for low-latency decisions, RF imaging capable of operating through concealment or jamming, and autonomous coordination without heavy infrastructure. Companies delivering practical, field-deployable solutions in these areas are well positioned to secure major contracts and partnerships with primes and government agencies. VWAV’s emphasis on RF-based sensing, its Evolved Intelligence™ AI frameworks, and quantum-inspired computational acceleration is designed to address precisely these operational pain points, creating asymmetric upside as defense shifts from legacy platforms toward intelligent, autonomous systems.

Recent Momentum: Strategic Announcements Over the Past ~2 Months (Dec 2025 – Feb 2026)

VisionWave has been highly active, using acquisitions, joint ventures, patents, and integrations to rapidly expand both capabilities and commercialization pathways. Notable developments include:

• December 2025: Signed a definitive agreement for its first acquisition, Solar Drone Ltd., expanding into drone and autonomous systems. This included follow-on hardware orders and distribution agreements in Italy and Spain for critical infrastructure applications with defense crossover potential. The company also announced issuance of a key U.S. patent (No. 12,499,578), strengthening protection around its core RF imaging and AI architecture.
• January 7, 2026: Acquired QuantumSpeed™ (branded qSpeed), a pre-commercial computational acceleration engine independently valued at approximately $99.6 million by BDO Consulting Group. The technology is designed to compress decision latency from minutes to seconds by prioritizing critical computations, with early integration into WaveStrike fire control and Argus counter-drone systems.
• January 12, 2026: Formed a strategic joint venture (Nevada LLC) to serve as a dedicated platform for expanding intellectual property, execution capabilities, and commercialization across defense, secure systems, and quantum-enhanced technologies.
• January 26, 2026: Entered into a strategic exchange agreement with SaverOne 2014 Ltd. (NASDAQ: SVRE) in a multi-stage transaction valued at roughly $7 million in equity consideration. The deal is aimed at creating an RF-based defense and security platform and could result in VisionWave holding approximately 51% of SaverOne on a fully diluted basis, subject to milestones and approvals. The combined technologies target concealed and non-line-of-sight threat detection, with progress already demonstrated through live RF-based VRU platform demonstrations.
• Late January–Early February 2026: Additional updates highlighted IP contributions from the Boca Jom JV (including EDA tools for semiconductor design), expansion of the technical team, continued progress on a dual-market (defense and commercial) autonomous systems platform, European growth through Solar Drone, and plans to invest up to $10 million in U.S.-based development to accelerate timelines. Financing activity, including loans tied to potential strategic transactions, underscores continued deal momentum.

Together, these moves point to aggressive execution: strengthening the technology stack, adding complementary assets (drones, acceleration engines, RF platforms), and positioning the company for a transition from pilots to contracts in 2026.

Strong Alignment: Insider Ownership and Institutional Interest

Insiders and affiliates reportedly control a significant ownership stake — figures cited around 55%, and in some contexts as high as roughly 69% when including closely held structures. This level of insider commitment creates strong alignment between management and shareholders in what remains a high-conviction, execution-driven story.

Institutional ownership and trading activity have also increased, with filings referencing firms such as Yorkville Advisors, Vanguard, Susquehanna, Citadel, and others, including a Goldman Sachs disclosure. Growing participation from sophisticated investors suggests rising awareness of the AI-defense narrative and the company’s recent strategic catalysts.

Positioned at the Intersection of AI and National Security

VisionWave Holdings sits at the forefront of a pivotal transformation in modern defense: the fusion of artificial intelligence with autonomous systems capable of detecting, deciding, and acting in real time. In a period defined by escalating global threats and record defense budgets, companies that master low-latency RF sensing, edge AI, and computational acceleration will help define the next generation of operational superiority across air, land, and sea.

The past two months have marked a period of rapid strategic progress. Acquisitions such as QuantumSpeed™, the creation of a focused technology joint venture, the high-impact partnership with SaverOne targeting non-line-of-sight threats, patent expansion, and accelerating integration milestones collectively show a company moving with urgency to translate innovation into deployable capability. These are foundational steps that broaden VisionWave’s intellectual property base and open potential pathways to both defense and critical infrastructure contracts.

Layered onto this operational momentum is notable alignment of interests: substantial insider ownership and increasing institutional engagement suggest that both internal stakeholders and professional investors see meaningful long-term potential. In a market increasingly rewarding early leaders in AI-enabled defense, that level of conviction stands out.

The coming quarters are likely to be decisive. For those focused on the scale of the autonomous defense opportunity and the execution now underway at VisionWave, this stage represents a pivotal setup — one where technological advancement, strategic positioning, and shareholder alignment are converging at a critical moment.

‍

Over the past two months, VisionWave appears to have executed a deliberate, multi-part strategy: bringing in specialized engineering talent, consolidating key intellectual property, and positioning dual-use technologies for both defense and commercial applications.

The SaverOne Deal: Structured for Accountability, Built for Capability

On January 26, 2026, VisionWave announced a definitive agreement to acquire approximately 51% of SaverOne 2014 Ltd. through a three-stage, milestone-based exchange. The real significance is not just the ownership stake, but the structure of the transaction.

Instead of a traditional one-step acquisition, VisionWave designed the deal with embedded performance checkpoints. Each milestone must be met before the next phase proceeds, creating a framework for measured integration and capital deployment. Both companies’ boards unanimously approved the agreement following independent fairness opinions from BDO Consulting Group.

As The Vanderbilt Report has noted, a large majority of mergers underperform expectations, often due to integration challenges. VisionWave’s phased structure introduces natural validation points before committing additional resources.

Operationally, the acquisition delivers immediate capability. VisionWave gains SaverOne’s RF-focused workforce — more than 30 engineers specializing in radio frequency technologies. This consolidation of talent could accelerate development of VisionWave’s VisionRF platform without the typical 12–24 month delay associated with building comparable teams from scratch.

Geography adds another layer of strategic value. Tel Aviv is widely recognized as a dense hub for RF and deep-tech innovation, providing VisionWave proximity to experienced engineers and research institutions with strong defense and advanced technology focus.

The market responded positively to the announcement. On the day of the news, VWAV rose 3.02%, adding roughly $5 million in market capitalization and bringing valuation to approximately $182 million.

IP Consolidation Points to an Execution Phase

Two days after announcing the SaverOne transaction, VisionWave completed an intellectual property transfer from Boca Jom Ltd. into the VisionWave–Boca Jom joint venture. This step suggests a shift from formation and structuring toward active execution with clearer commercialization pathways.

In today’s innovation-driven economy, intangible assets such as IP often represent the majority of enterprise value among leading companies. VisionWave’s effort to consolidate IP under structured entities positions it to compete on proprietary technology rather than cost or scale alone — a critical factor in defense markets where technical differentiation often determines contract outcomes.

Addressing Real-World Sensor Limitations

VisionWave is developing RF sensing technologies designed to operate in environments where optical and LiDAR systems face limitations. Conventional sensors can struggle with occlusion, cluttered terrain, poor weather, and complex infrastructure. VisionWave’s focus is on detecting concealed, obscured, and non-line-of-sight threats — scenarios where traditional sensing approaches are less effective.

The company’s dual-market strategy spans defense and commercial use cases. VisionWave intends to integrate its RF technologies into SaverOne’s existing vulnerable road user detection platform, enhancing it with RF sensing and AI-driven analytics for challenging scenarios such as obscured pedestrians, non-line-of-sight risks, adverse weather, and dense urban environments.

Management has indicated that an RF-enhanced, commercially deployable solution could potentially be demonstrated during calendar year 2026, subject to continued development and validation.

Market Timing and Sector Tailwinds

VisionWave’s recent moves align with broader defense technology trends. The cognitive electronic warfare market is projected to grow steadily, driven by demand for AI-enabled systems capable of adapting to complex electromagnetic environments in real time.

At the same time, institutional focus on edge AI continues to increase. Processing data directly on platforms — rather than relying on distant cloud infrastructure — enables the low-latency decision-making required in operational settings. This is closely aligned with VisionWave’s emphasis on near-field RF sensing and edge-based intelligence.

SaverOne’s existing international footprint may also provide VisionWave with additional entry points into procurement channels across multiple regions, while the exchange structure could help SaverOne expand into defense segments that were previously outside its core reach.

Strategic Coherence

Taken together, VisionWave’s actions outline a cohesive strategy: milestone-based acquisitions, IP consolidation, and dual-use technology positioning. Rather than competing directly with large incumbent defense contractors, the company appears focused on addressing specific capability gaps in current sensor and detection systems.

The alignment between engineering talent acquisition, IP development, and diversified market positioning suggests a methodical approach to execution. Talent supports innovation, innovation builds defensible IP, and dual-market exposure may help mitigate reliance on any single customer segment.

At a market capitalization near $182 million, VisionWave is still viewed as an early-stage, development-focused defense technology company. Investor interest appears to reflect cautious optimism around its ability to demonstrate commercial viability as a precursor to longer-cycle defense opportunities — a pathway that has historically helped de-risk emerging defense technologies.

VisionWave’s Counter-UAS Systems Featured by a U.S. Tier-1 Defense Partner at Association of the United States Army – AUSA 2025

Showcasing joint innovation and deepening collaboration at one of North America’s largest defense exhibitions

WEST HOLLYWOOD, Calif., Oct. 22, 2025 /PRNewswire/ — VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave” or the “Company”) today announced that its Counter-Unmanned Aerial System (C-UAS) technologies were featured and installed on a Tier-1 U.S. defense contractor’s platform during the Association of the United States Army (AUSA) Annual Meeting and Exposition held October 13–15, 2025, in Washington, D.C. one of North America’s largest and most influential defense exhibitions.

The joint display positioned VisionWave’s C-UAS system as a centerpiece integration, reflecting the strong partnership, technological confidence, and potential advantages that VisionWave brings to its defense partners. It is the goal for the collaboration between the companies to continue to grow stronger, with multiple new projects, integration efforts, and combined design initiatives now underway – illustrating the depth of the expanding relationship and potential opportunities ahead.

“We believe being showcased on a major defense partner’s platform at AUSA highlights the strength of our collaboration and the confidence placed in our technology,” said Noam Kenig, Chief Executive Officer of VisionWave. “This partnership is becoming even closer with the goal of introducing more programs and integration projects and establishing joint design efforts. It’s an exciting step forward for both companies.”

The installation demonstrated seamless interoperability with modern command-and-control frameworks and emphasized real-time multi-domain readiness for operational environments.

Key highlights:

• Prime-level exposure: VisionWave’s C-UAS systems presented publicly for the first time as part of a Tier-1 contractor’s operational platform.
• Deepening collaboration: Builds on ongoing joint engineering and integration work across unmanned, sensing, and protection systems.
• Technological validation: Reinforces VisionWave’s potential advantage in AI-driven sensing and autonomous defense technologies.

‍

VisionWave’s combat-proven solutions are designed to enhance security, enable multi-domain operations, and drive innovation in defense and homeland security. Leveraging AI and computer vision-powered operating systems, we connect intelligent devices and hardware assets, ensuring seamless integration for maximum operational efficiency. Our advanced hardware and software applications provide real-time surveillance enhancements across air, land, and sea.

Their team excels in sectors critical to modern defense, including autonomous systems, advanced imaging, high-resolution radar, RF sensing, remote weapon systems, and micro-mobility platforms. With over 50 granted patents and a proven track record of success in commercial, medical, space, aerospace, and defense applications, VisionWave delivers combat-ready solutions that provide security awareness, multi-domain launch capabilities, and survey, inspection, and intelligence solutions across diverse environments.

VisionWave Technologies is committed to pushing the boundaries of defense technology, driving the future of innovation, and ensuring performance and reliability in the most demanding conditions.

ARTIFICIAL INTELLIGENCE

With extensive experience and a portfolio of globally approved patents, VisionWave is a leader in AI-driven solutions for defense, military, and law enforcement. Our proprietary AI engine powers a wide range of applications, from enhancing image quality for surveillance and intelligence to managing autonomous vehicles and remote weapon control systems.

When it comes to unmanned & remote weapon systems, VisionWave’s AI plays a pivotal role in managing both aerial and ground-based autonomous vehicles & weapons. By automating navigation, threat detection, and mission execution, our technology allows these vehicles & weapons to operate with high levels of precision and reliability in complex, high-risk environments. This reduces human exposure to danger while improving the effectiveness of missions, whether for military operations, disaster response or law enforcement.

In the realm of image enhancement and restoration, VisionWave’s AI engine enables the transformation of low-quality, incomplete visual data, & different sensing signals into clear, actionable images that provide insights. Whether used for surveillance, reconnaissance, or intelligence gathering, this capability allows operators to work with enhanced visual fidelity, even in low-light or obscured environments, ensuring critical details are captured and understood

VisionWave stays at the forefront of AI innovation by continuously monitoring advancements and developing cutting-edge technologies that shape the future of defense and security, ensuring our solutions are ready to meet both current and emerging challenges.

SENSING TECHNOLOGIES

VisionWave’s multi-patented Vision-RF system revolutionizes RF signal transformation, converting signals into real-time video for groundbreaking applications such as underground and behind-wall detection, aerial threat identification, and medical imaging.This innovative technology sets new industry standards, expanding the possibilities for real-time Vision-RF-based solutions.Our proprietary, cost-effective high-resolution radar technology, combined with super-resolution AI algorithms, delivers LIDAR-like outputs with unmatched precision and compactness.When integrated with our event-based imaging technology, these solutions are ideal for autonomous vehicles, remote weapon systems, Active Protection Systems (APS), and security applications. With a robust patent portfolio, VisionWave offers custom, cost-effective sensing solutions that ensure reliability and accuracy, even in the most challenging environments.

UNMANNED VEHICLES

VisionWave Technologies is home to a team of experts and combat-proven platforms used worldwide in unmanned systems, specifically designed for military and homeland security applications where long endurance and sensitive data collection are required.We offer a range of AI-powered autonomous platforms for air, ground, and sea, engineered to excel in the toughest conditions.Combining our proprietary sensing technologies, VisionWave’s unmanned vehicles consistently outperform competitors, driving the future of autonomous systems.

TACTICAL PLATFORMS

VisionWave redefines mobility with our micro-ATV platform, specifically designed for robust environments required by homeland security and military applications.Drawing on years of experience in the field, we have created one of the most unique platforms on the market. Featuring high maneuverability and a four-wheel-drive system, it outperforms other solutions by offering quiet, stealthy mobility—ideal for tactical special forces, law enforcement, and rapid medical deployments.The durability and silent drive of the micro-ATV provide significant advantages over gas-powered alternatives, making it a crucial asset for specialized missions where fast ground mobility is required.\

NEWS

RF-Based VRU Safety Platforms Positioned for Institutional-Scale Growth

3 days ago

Multi-Billion-Dollar VRU Detection Market Unlocking New Growth Opportunities

3 days ago

VisionWave Holdings Announces Succesful Live Demonstration of SaverOne’s (Nasdaq: SVRE) RF-Based VRU Platform

3 days ago

THE SOVEREIGNTY DOCTRINE: 5 Assets Locking Down the 2026 Survival Cycle

4 days ago

Defense Capital Shift: The $29B Autonomous Shield Market

4 days ago

Vanderbilt Report: VisionWave’s Strategic Acquisitions Position Company for Defense Market Expansion

6 days ago

The $161B Shift: How New Tech is Shrinking Battlefield Decision Times

6 days ago

VisionWave Holdings Highlights Dual-Market Autonomous Systems Platform and Advances RF-Based Defense Capabilities, Incorporating QuantumSpeed™ and advancing qSpeed™ Computational Acceleration Architecture

6 days ago

VisionWave and Boca Jom, Ltd. Near Completion of AstraDRC™ POC, a Patented Automatic DRC Violation Correction Platform for Advanced AI Microchips

Feb 2, 2026

$1 Trillion Defense Surge: Record Aftermarket Demand and AI Tech Integration

Jan 30, 2026

National Defense Strategy Ignites 2026 Deep Tech Valuation Surge

Jan 29, 2026

VisionWave Holdings Announces IP Contribution by Boca Jom Joint Venture and Assembly of Technical Teams

Jan 28, 2026

Defense Stocks Ignite as $900 Billion Pentagon Budget Triggers AI Tech Revolution

Jan 27, 2026

/C O R R E C T I O N — Market News Updates/

Jan 26, 2026

VisionWave Holdings and SaverOne Announce Execution of Strategic Exchange Agreement to Establish RF-Based Defense Platform

Jan 26, 2026

$233B Engineering Supercycle: Bridging the Autonomous Action Gap in 2026

Jan 20, 2026

Next-Gen Defense Technologies Moving from Concept to Large-Scale Deployment

Jan 20, 2026

VisionWave Advances qSpeed™ Pre-Commercial Computational Acceleration Architecture Across Defense Programs, Including Fire Control, Counter-UAS, and Intercept Workflows Where Microseconds Matter

Jan 20, 2026

Solar Drones Unlocking a Multi-Billion-Dollar Flight Economy as Investors Hone in on New Opportunity

Jan 15, 2026

VisionWave Holdings, Inc. Announces European Expansion with Follow-On Order and Strategic Distribution Agreement in Italy and Spain

Jan 15, 2026

Management

‍

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF FIFTEEN THOUSAND USD BY SPARK NEWSWIRE INC FOR A ONE DAY VWAV AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

***Sponsored by LFG Equities Corp

‍

Revenues increased significantly by 119% from $70.8 million in 2023 to $155.2 million in 2024

For the six months ended June 30, 2025, Total revenues increased to approximately $114.6 million

The Company supplied marine fuels to 359 vessels this year—an 80% increase from 200 vessels in 2024

Uni-Fuels Secures Letter of Award for Strategic Three-Year Fuel Procurement Supply

________________________

Hello Everyone,

We are back with a past winner to take a look at that is sitting at what could be a critical bounce point. UFG has been red 5 of the last 6 so this could potentially be bargain prices for this one. Keep in mind it is still well above where we first took a look at this one back in December around .85, prior to its explosive run all the way to $1.56 in less than a month. Thats a hair under 85%. UFG is sitting just under a dollar but has a lot of incentive to stay on the other side of .99.

The company outlined its strategy to expand its presence in major shipping hubs while evaluating potential strategic opportunities, including acquisitions that align with its long-term growth objectives. This announcement follows Uni-Fuels’ earlier expansion to Dubai, Shanghai, and Limassol in 2025.

Uni-Fuels’ expansion priorities include supporting shipowners across global shipping routes, maintaining operational discipline, addressing increasing market and regulatory complexity, supporting diverse marine fuel requirements, and strengthening its scale and geographic reach.

The company plans to prioritize organic growth by expanding its team, deepening customer relationships, and increasing market coverage in key regions such as Europe and the Americas. Uni-Fuels will also enhance partnerships with physical suppliers and logistics providers to support efficient fuel supply across its global network.

The company’s strategy addresses evolving industry challenges including the implementation of the EU Emissions Trading System and FuelEU Maritime regulations, which affect voyage economics and fuel selection for shipping companies.

UFG just IPO’d this time last year in January. What we have on our hands is a fast-growing global provider of marine fuel solutions with offices across major shipping hubs including Singapore, Seoul, Dubai, and Shanghai, continues its rapid expansion with the opening of its first European office in Limassol, Cyprus. Established in 2021 and backed by a diverse team of over 30 professionals, Uni-Fuels has built a strong reputation for customer-centric, compliant, and reliable 24/7 global fuel operations. The global marine fuels industry is very large and estimated to reach $140.6 billion in 2025 so even small market share gains should create substantial revenues for the company.

The new Limassol office—alongside this year’s openings in Dubai and Shanghai—marks a pivotal milestone in strengthening the Company’s international footprint, enabling deeper engagement with European markets and enhancing operational agility across high-demand maritime corridors. “Our new Limassol office highlights our ethos of being closer to our customers and major trading hubs, where proximity to our working partners and key shipping routes matters,” said Alan Tan, Senior Vice President of Commercial. Positioned at the intersection of traditional fuel markets and emerging green shipping corridors, Cyprus provides a strategic gateway for Uni-Fuels to diversify its supplier base, reinforce supply resilience, and scale its certified alternative and low-emission fuel offerings.

The company trades and brokers various marine fuel products, including Very Low Sulphur Fuel Oil (VLSFO), High Sulphur Fuel Oil (HSFO), Marine Gas Oil (MGO) and Bio Marine Fuel (BMF). These products are supplied to a variety of marine vessels globally, both in-port and offshore.

In addition to fuel-related services, Uni-Fuels occasionally offers ancillary shipping services such as the arrangement of ship agents, ship provisions, and marine fuel surveyors. The company leverages its advanced, integrated capabilities and extensive global supply network to deliver comprehensive and competitive solutions.

Uni-Fuels operates through two business models: direct fuel sales and brokerage services.

• Under the sales model, Uni-Fuels manages the entire customer relationship and transaction process. It provides value-added services such as trade credit, financing, risk management, market intelligence, and operational expertise. The company guarantees fuel delivery to the customer while sourcing the fuel from third-party suppliers.
• In the brokerage model, Uni-Fuels acts as an intermediary between fuel suppliers and customers, earning a commission for its services. However, this line of business is currently being deemphasized as the company focuses more on its core sales operations.

As the maritime sector accelerates toward decarbonization, Uni-Fuels is poised to capitalize on this industry-wide energy transformation by coordinating innovative sourcing strategies aligned with evolving environmental regulations and sustainability targets. With its expanding global network, robust supply partnerships, and commitment to operational excellence, Uni-Fuels is primed for continued growth as it supports the maritime industry in achieving reliable, efficient, and future-ready fuel solutions.

In 2024, Sales of Marine Fuels reached US $155.2 million, an increase of US $85.0 million, 121% Year-Over-Year, compared to approximately US $70.2 million in 2023.

2025 looks like it could be even better based on a press release the company put out back in October. Uni-Fuels delivered exceptional growth this year, underscoring its accelerating global momentum and strengthening market position. Transaction volumes surged 75% year-over-year to 502, up from 287 in the prior-year period, while total marine fuel deliveries rose 90% to approximately 217,000 metric tons compared with 114,000 metric tons a year earlier. The Company supplied marine fuels to 359 vessels—an 80% increase from 200 vessels in the same period last year—reflecting a sharp rise in customer demand and operational scalability. Uni-Fuels also expanded its global footprint significantly, operating across 103 ports worldwide, nearly doubling last year’s coverage of 52 ports. Further demonstrating the Company’s ability to deepen and diversify its commercial relationships, the customer base grew to 179, up 106% from 87 in the prior-year period. These strong performance indicators highlight Uni-Fuels’ continued growth trajectory, expanding market relevance, and ability to execute in a rapidly evolving maritime energy landscape.

MAJOR CATALYSTS

Aggressive Global Expansion: Uni-Fuels opened three new offices in 2025 (Dubai in April, Shanghai in June, and Limassol, Cyprus in November), marking its first European foothold and strengthening presence across Asia, Middle East, and Europe—positioning the company closer to key shipping hubs and customers.

Explosive Operational Growth: H1 2025 transaction volumes surged 75% YoY to 502, fuel deliveries jumped 90% to 217,000 metric tons, vessels supplied rose 80% to 359, ports served nearly doubled to 103 (+98%), and customer base grew 106% to 179—demonstrating rapid market share gains.

Robust Revenue Momentum: H1 2025 revenues climbed 54% YoY to $114.6M; full-year 2024 revenues soared 119% to $155.2M, driven by a 121% increase in marine fuel sales—validating the scalability of its physical supply model over brokerage.

Improving Gross Profit Trajectory: Despite margin pressure from competitive pricing to gain share, gross profit rose 42% YoY to $2.1M in H1 2025 and 40% to $3.2M for full-year 2024, with management emphasizing this strategy sets the stage for long-term profitability.

Successful Nasdaq Listing & Capital Raise: Completed January 2025 IPO raising $9.66M gross (including full over-allotment), providing permanent capital to fuel expansion and enhancing liquidity and visibility as a U.S.-listed entity (NASDAQ: UFG).

Strong Investor Confidence via Oversubscribed Debt: Two $3M commercial paper issuances on Singapore’s ADDX platform in 2025 were oversubscribed and the first one was fully repaid on schedule, diversifying funding sources and reinforcing investors belief in Uni-Fuels’ growth story. The investors are all accredited investors from Singapore not institutional.

Sustainability Credentials Strengthened: Secured ISCC EU and ISCC PLUS certifications in February 2025, enabling compliant biofuel trading under EU RED II and positioning the company to capture rising demand for low-emission marine fuels.

Strategic Shift to Higher-Margin Direct Fuel Sales: Deliberately reduced brokerage commissions (down 98% in 2024) to focus resources on direct marine fuel sales, nearly doubling customers and ports served—laying foundation for greater revenue control and stickier client relationships.

Enhanced Supply Chain Resilience: New offices in major bunkering hubs (Dubai near Fujairah, Shanghai, Limassol) provide real-time market intelligence, localized expertise, and diversified supplier networks, improving pricing agility and delivery reliability.

Positive Management Outlook: CEO Koh Kuan Hua highlighted “compelling growth opportunities” and confidence in sustained revenue and gross profit expansion in 2025, backed by geographic scale-up, operational efficiencies, and a robust pipeline of global supply partnerships.

Uni-Fuels Secures Letter of Award for Strategic Three-Year Fuel Procurement Supply

SINGAPORE, Dec. 10, 2025 (GLOBE NEWSWIRE) — Uni-Fuels Holdings Limited (NASDAQ: UFG), (“Uni-Fuels” or the “Company”), a global provider of marine fuel solutions based in Singapore, today announced that its wholly-owned subsidiary, Uni-Fuels Pte Ltd (“Uni-Fuels Singapore”), has received a Letter of Award (“LOA”) for a three-year supply of marine fuels from a leading provider of engineering, procurement, construction, and installation (“EPCI”) contractor of offshore oil and gas projects in the Asia Pacific region.

Under the terms of the LOA, which will commence from 1st January 2026, Uni-Fuels Singapore will provide comprehensive marine fuel solutions, leveraging its extensive local supply network to ensure consistent marine fuel supply and compliance with regulatory standards. This award marks a pivotal milestone in market validation, reflecting deepening industry trust in Uni-Fuels and affirming growing customers’ confidence in Uni-Fuels’ operational expertise, reliability, and ability to support offshore oil and gas projects.

“This strategic award underscores Uni-Fuels’ position as a trusted partner in the marine fuel industry,” said Ms Stefanie Tay, Chief Operating Officer of Uni-Fuels. “It reinforces our reputation for delivering high-quality, tailored solutions to our clients and highlights the scalability of our operations to support growing demand across the Asia Pacific region. We remain focused on strengthening our operational capabilities and ensuring disciplined execution to drive the Company’s growth and long-term value creation.”

The award is expected to contribute positively to Uni-Fuels’ revenue over the next three years, further strengthening the Company’s long-term growth trajectory in its marine fuel business.

Uni-Fuels Announces 2025 Interim Financial Results

Strong Operational Performance Drives Revenue and Gross Profit Growth

SINGAPORE, Oct. 28, 2025 (GLOBE NEWSWIRE) — Uni-Fuels Holdings Limited (NASDAQ: UFG), (“Uni-Fuels” or the “Company”), a global provider of marine fuel solutions headquartered in Singapore, today announced its interim financial results for the six months ended June 30, 2025.

Key Strategic Developments        

• On February 12, 2025, the Company’s wholly owned subsidiary, Uni-Fuels Pte Ltd (“Uni-Fuels Singapore”), received ISCC EU and ISCC PLUS certifications from the International Sustainability and Carbon Certification (“ISCC”). The ISCC certifications ensure that the biofuels traded by Uni-Fuels Singapore meet the requirements of the European Union’s (“EU”) Renewable Energy Directive (“RED II”), including the provision of Proof of Sustainability (“POS”).
• On April 2, 2025, the Company, as part of its global expansion strategy, announced the establishment of Uni-Fuels Middle East FZCO (“Uni-Fuels Dubai”), a wholly owned subsidiary of the Company, in the United Arab Emirates and the opening of a new office in Dubai.
• On June 30, 2025, the Company announced the opening of a new office in Shanghai. The formation of the wholly owned subsidiary, Uni-Fuels (Shanghai) Co Ltd (“Uni-Fuels Shanghai”), reinforces the Company’s commitment to strengthening its Asian market presence.
• On July 21, 2025, the Company announced Uni-Fuels Singapore has successfully completed the Company’s first-ever commercial paper (“CP”) issuance, raising US$3 million through ADDX Exchange, a private market platform regulated by the Monetary Authority of Singapore. The Company’s 3M USD Commercial Paper Series 001 has since been fully repaid on October 17, 2025. Subsequently, on October 17, 2025, the Company announced that Uni-Fuels Singapore has successfully closed its 3M USD Commercial Paper Series 002 on the ADDX Exchange, and that it has raised US$3 million in gross proceeds. The Series 002 tokens were listed on the ADDX Exchange on October 18, 2025. Through the issuance of the CPs, the Company seeks to reinforce its liquidity position and enhance its capital structure, positioning it to pursue new growth opportunities. Both the offerings were oversubscribed, reflecting strong demand from accredited investors.

Key Operational Highlights

During the six months ended June 30, 2025, the Company’s marine fuels business delivered strong momentum.

• Transaction volumes surged 75% period-over-period to 502, up from 287 in the prior-year period.
  
• Total marine fuel deliveries increased by 90% to approximately 217,000 metric tons, compared with approximately 114,000 metric tons a year earlier.
  
• The Company supplied marine fuels to 359 vessels, representing an 80% increase from 200 vessels in the same period last year.
  
• Operations expanded to 103 ports, representing a 98% increase from 52 ports a year ago, reflecting broader global coverage and customer reach.
  
• The Company strengthened its customer base, serving 179 customers, an increase of 106% from 87 customers in the prior-year period.

Key Financial Highlights

For the six months ended June 30, 2025, the Company achieved strong financial performance across its marine fuels business.

• Total revenues increased to approximately US$114.6 million, up approximately US$40.4 million or 54% period-over-period from US$74.2 million in the same period last year, reflecting stronger sales momentum across key markets and expanded business activities.
  
• Cost of revenues rose to approximately US$112.6 million, an increase of approximately US$39.8 million or 55% period-over-period from US$72.7 million during the six months ended June 30, 2024, in tandem with the increase in the volumes of marine fuels sold and the associated cost of revenues.
  
• As a result, gross profit improved to approximately US$2.1 million, up approximately US$0.6 million or 42% period-over-period from US$1.5 million, supported by increased sales volumes and operational efficiencies in the marine fuels business.
  
• Total operating expenses increased to approximately US$1.9 million, an increase of approximately US$0.5 million or 40% period-over-period from US$1.4 million, primarily due to continued investment in business development, operational capabilities, and strategic initiatives to support growth.
  
• Net income before tax was approximately US$0.2 million, an increase of approximately US$0.1 million or 73% period-over-period from US$0.1 million, reflecting the combined impact of higher revenues, increased cost of sales, and growth-related operating expenses.
  
• Net income after tax for the period was approximately US$90,000, lower than the same period last year by approximately US$11,000 or 11% from US$102,000, due to higher tax expenses incurred by Uni-Fuels Singapore.

Management Commentary

“The Company has continued its growth trajectory during the first half of 2025, characterized by incremental revenue growth despite a confluence of challenges in an uncertain economic climate. This is a testament to our commitment to creating greater shareholder value. We are executing our strategic priorities and broad growth roadmap effectively. As part of our global expansion plan, we have increased our geographical presence, spanning Dubai and Shanghai. Our strategic capital raises will further augment our liquidity position and enable the next phase of our expansion plan,” underlined Koh Kuan Hua, Chairman & CEO of Uni-Fuels.

“Our financial results reaffirm the compelling growth opportunities across our business model. We will continue to solidify our market position, expand our market reach, and build an extensive pipeline of reliable global supply network to support clients’ operational goals and deepen stronger, trusted partnerships through enhanced business partners proximity,” added Koh Kuan Hua.

The Company, capitalizing on its expanding international footprint and enhanced operational efficiency, is well positioned to deliver sustained revenue and gross profit growth in 2025. Bolstered by recent market expansion initiatives, operational improvements, and scale-up momentum in its core business, the Company remains focused on driving long-term growth and delivering strategic value to shareholders.

Uni-Fuels Advances Global Operations with Next Phase of Expansion

SINGAPORE, Jan. 05, 2026 (GLOBE NEWSWIRE) — Uni-Fuels Holdings Limited (NASDAQ: UFG), (“Uni-Fuels” or the “Company”), a global provider of marine fuel solutions headquartered in Singapore, today announced the next phase of its global expansion strategy, focused on scaling its global operations through disciplined organic growth across key maritime markets. As part of this approach, the Company is evaluating potential strategic opportunities, including, among others, acquisitions, over time, where such opportunities align with its long-term growth strategy.

This announcement builds on Uni-Fuels’ expansion to Dubai, Shanghai, and Limassol in 2025 and provides the strategic framework for additional office openings and operational initiatives designed to support long-term corporate development.

As part of this next phase, Uni-Fuels’ expansion strategy is guided by the following priorities:

• Supporting shipowners and operators across global shipping routes, including both major trade corridors and niche ports, with consistent service and execution standards
• Maintaining strong operational discipline, including counterparty risk management and regulatory compliance, as the Company scales its activities
• Addressing increasing market and regulatory complexity, including the implementation of decarbonization-related measures such as the EU Emissions Trading System (EU ETS), which directly affect voyage economics, fuel selection, and emissions compliance obligations
• Supporting a growing diversity of marine fuel requirements, including conventional, transitional, and emerging fuels, as customers adapt fuel strategies in response to emissions-related cost considerations and fuel-intensity regulations such as FuelEU Maritime
• Strengthening scale, operational capability, and broadening geographic reach to meet customer needs in an evolving global bunker and regulatory landscape

In executing this next phase, Uni-Fuels will prioritize organic growth by expanding its team, deepening customer relationships, and increasing market coverage in key regions, such as Europe, the Americas, and other major international shipping hubs. The Company will also continue to enhance partnerships with physical suppliers, logistics providers, and counterparties to support efficient, reliable, and resilient fuel supply across its global network.

As noted above, the Company may from time to time evaluate strategic opportunities, subject to market conditions, necessary approvals, and strategic fit. Any such opportunities would be considered with a focus on financial discipline, cultural fit, and the potential to enhance the Company’s existing trading and operational capabilities.

“This next phase of expansion reflects our focus on scaling Uni-Fuels’ global operations in a disciplined and measured manner,” said Mr. Koh Kuan Hua, Chief Executive Officer of Uni-Fuels. “As bunker markets evolve, shaped by increasing regulatory complexity, decarbonization measures, and a growing range of marine fuel requirements, we are strengthening our operational capabilities and geographic reach to support customers across an increasingly complex bunker landscape, while maintaining high standards of operational discipline, risk management, and regulatory compliance. We are investing organically to expand our market coverage and business capabilities, while remaining open to strategic opportunities that align with our long-term objectives.”

Uni-Fuels Enhances End-to-end EU ETS Compliance Solutions for Global Shipping Companies with EU Allowance Support

SINGAPORE, Jan. 20, 2026 (GLOBE NEWSWIRE) — Uni-Fuels Holdings Limited (NASDAQ: UFG) (“Uni-Fuels” or the “Company”), a global provider of marine fuel solutions headquartered in Singapore, today announced that the Company’s wholly owned subsidiaries, Uni-Fuels Pte Ltd (“Uni-Fuels Singapore”) and Uni-Fuels Middle East FZCO (“Uni-Fuels Dubai”), are offering EU Allowances (EUAs) to support shipowners and operators in complying with the European Union Emissions Trading System (EU ETS) as it extends to maritime transport.

The EUA solution complements the suite of marine fuel offerings provided by Uni-Fuels’ subsidiaries and reflects the Company’s strategy of delivering value-driven, end-to-end solutions. This launch reaffirms Uni-Fuels’ continued commitment to sustainability by supporting customers as they navigate evolving regulatory requirements while aligning operational priorities with environmental compliance.

Under the EU ETS, shipowners are required to monitor and verify their vessels’ missions and surrender a corresponding number of EUAs annually to cover the verified emissions. The regime was extended to maritime transport, effective January 1, 2024, with a phased implementation that requires allowances for 40% of verified emissions in 2024, increasing to 70% in 2025, and reaching full compliance from 2026 onward. Failure to surrender sufficient allowances may result in financial penalties and enforcement actions, underscoring the importance of reliable access to EUAs.

“With a growing need for greater operational transparency and environmental commitment across global maritime operations, shipowners and operators are facing a significant regulatory shift,” said Ms. Stefanie Tay, Chief Operating Officer of Uni-Fuels. “Our subsidiaries are committed to supporting our customers through this transition by providing reliable access to EUAs alongside the core services they already trust, helping them manage risk, remain compliant, and make informed decisions in an evolving regulatory landscape.”

Ms. Stefanie Tay continued, “This initiative marks a landmark step in Uni-Fuels’ 2026 global strategic roadmap, focusing on scaling operations and broadening service offerings to meet emerging customer needs across the global maritime sector. The EUA offering strengthens the Company’s value proposition by helping shipowners and operators efficiently meet compliance requirements while focusing on their core operations.”

‍

NEWS

Uni-Fuels Enhances End-to-end EU ETS Compliance Solutions for Global Shipping Companies with EU Allowance Support

Jan 20, 2026

Uni-Fuels Advances Global Operations with Next Phase of Expansion

Jan 5, 2026

Uni-Fuels Secures Letter of Award for Strategic Three-Year Fuel Procurement Supply

Dec 10, 2025

Uni-Fuels Continues to Strengthen Global Operations with A New Office in Limassol, Cyprus

Nov 11, 2025

Uni-Fuels Announces 2025 Interim Financial Results

Oct 28, 2025

Uni-Fuels Completes First Oversubscribed USD 3 Million Commercial Paper Issuance on ADDX

Jul 21, 2025

Uni-Fuels Strengthens Asian Market Presence with A New Office in Shanghai

Jun 30, 2025

Uni-Fuels Announces Full Year 2024 Financial Results

Apr 22, 2025

Uni-Fuels Establishes UAE Subsidiary and New Office in Dubai

Apr 2, 2025

Uni-Fuels Awarded International Sustainability and Carbon Certifications, Reinforcing Commitment to Sustainable Marine Fuel Trading

Feb 12, 2025

Management

‍

‍

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF FIFTEEN THOUSAND USD BY LFG EQUITIES CORP FOR A ONE DAY UFG AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

**Sponsored by SurfAir Mobility

Surf Air Mobility flew over 310,000 passengers across 63,000 flights on their large fleet of Cessna Grand Caravans in the last 12 months ending September 30, 2025 — making it one of the largest commuter airlines in the U.S.

SRFM has exclusive agreements with multi-billion dollar market cap company Textron Aviation (NYSE:TXT), one of the world’s largest general aviation manufacturers and an exclusive strategic relationship with Palantir Technologies (NASDAQ:PLTR), leveraging cutting-edge AI and data analytics –Entering into a Five-Year Agreement with Palantir, Expanding Relationship to Include Exclusivity for the Part 135 Regional Air Mobility Market

CHECK OUT THE MOST RECENT INVESTOR PRESENTATION HERE

_______________________

Hello Everyone,

Surf Air Mobility is building an AI-enabled operating platform for the air mobility sector, powered by Palantir’s Foundry and AIP. The initiative centers on SurfOS, a next-generation aviation software system designed to modernize the private aviation and air mobility industries.

The company has allocated $26 million from its recent $100 million strategic transaction specifically for SurfOS development. This funding supports AI capabilities and deeper integration with Palantir’s data infrastructure, with the goal of improving operational efficiency, route optimization, and overall airline economics.

Management is targeting a commercial software rollout in 2026. The long-term objective is to enhance reliability and profitability across private aviation and regional aviation networks through smarter, data-driven decision systems.

Two analyst price targets released recently imply potential upside relative to the company’s most recent trading levels.

Why the Story is Interesting

The broader aviation market is evolving. Travelers increasingly prioritize flexibility, affordability, and sustainability — areas where traditional hub-and-spoke carriers often struggle due to fixed schedules and high operating costs.

Surf Air Mobility is positioning itself as a software-first aviation company, using AI to streamline scheduling, fleet utilization, maintenance planning, and customer experience. Rather than relying solely on hardware innovation, the company is focusing on the operating system layer that could power the next phase of regional air travel.

A key component of the long-term strategy is preparing the ecosystem for electrified aircraft, which could significantly lower short-haul operating costs and reduce emissions once regulatory certification is achieved.

Additionally, existing interline agreements with major airlines may help integrate regional routes into larger travel networks, potentially improving passenger connectivity and load factors.

As always, emerging aviation and technology platforms carry execution, regulatory, and capital-intensity risks, so this remains a developing story rather than a finished one.

The Los Angeles-based air mobility platform is one of the largest commuter airlines in the US by scheduled departures. Over the 12 months ended September 30, the company has flown more than 310,000 passengers across 63,000 flights using a fleet of Cessna Grand Caravans, cementing its position as a key operator in air mobility.

The Surf Air Mobility platform brings together two complementary business units that connect near-term operations with long-term technology growth.

• Air Mobility: scheduled service, on-demand charters, and interline partnerships with major carriers that generate consistent revenue and cash flow.
• Air Technology: proprietary aviation software (SurfOS™) and electrification initiatives designed to improve efficiency, margins, and scalability across the network.

This dual-pronged model allows Surf Air Mobility to operate as both an established airline and an emerging aviation technology company — combining a proven operational footprint with the potential of software-driven and electrified flight.

The company is reimagining regional air travel through technology and data. Its proprietary platform, SurfOS, is an AI-enabled suite powered by Palantir Technologies (NASDAQ:PLTR), a multi-billion dollar global leader in data analytics.

Palantir’s software helps power some of the most complex systems in the world, from national defense to major financial institutions. By integrating that same intelligence into aviation, Surf Air Mobility is creating a smarter, more connected flight network.

The system is designed to optimize flight routes, manage scheduling, and improve efficiency across Surf Air Mobility’s fleet of aircraft. It is a step toward modernizing regional travel through software that learns, adapts, and scales.

A lot has happened with the SRFM since we first started looking at the company almost 18 months ago.

In October, Surf Air Mobility strengthened its team with the addition of Shawn Pelsinger, the former Global Head of Corporate Development & Senior Counsel at Palantir Technologies, to its Board of Directors.

Pelsinger spent nearly a decade helping shape Palantir’s aviation and enterprise partnerships, including the creation of Skywise, the aviation data platform built with Airbus, and the 2021 collaboration that launched SurfOS.

Now, he’s returning to the story, this time on the SRFM side.

With Palantir as a large shareholder in Surf Air Mobility, Shawn’s addition deepens an already strategic relationship and reinforces SRFM’s position as one of the few air mobility companies operating with enterprise-grade AI infrastructure.

At the same time, Surf Air Mobility continues to show meaningful operational and financial progress. In the third quarter of 2025, the company reported $29.2 million in revenue, beating expectations of $27-28.5 Million. As compared with the second quarter, revenue increased 6% driven by a 42% increase in On Demand revenue, partially offset by a 4% decrease in Scheduled Service revenue

Airline operations turned profitable back in Q2 on an Adjusted EBITDA basis, supported by improved completion rates, stronger on-demand margins, and cost efficiencies driven in part by its technology integration. These results mark a clear turning point as management continues executing on its multi-phase strategy.

The company has also been taking some serious steps towards its transformation plan.

Phase 1: Transformation (Completed 2024)

The first phase focused on establishing financial stability and operational readiness. By the end of 2024, Surf Air Mobility had strengthened its balance sheet, secured $44.7 million in equity capital, and extended the maturity of its secured debt to 2028. The company also reduced legacy liabilities and completed the integration of its merger with Southern Airways, realizing $6.5 million in M&A synergies.

Phase 2: Optimization (2025–2026)

The current phase emphasizes profitability, performance, and technology deployment and progress is already clear.

Milestones achieved on the Optimization phase of the Transformation Plan included:

Optimizing Airline Operations

• Achieved second consecutive quarter of profitability in the Company’s airline operations, defined as positive Adjusted EBITDA
• Continued improvement in key operating measures, including on-time departure, on-time arrival, and controllable completion, demonstrating the permanency of transformation strategies

• Improved key performance indicators such as on-time departures, arrivals, and controllable completion rates by double-digit percentages compared with the prior year.
• Achieved profitability in airline operations for the second quarter of 2025 on an adjusted EBITDA basis.
• Secured a new interline agreement with Japan Airlines, the company’s fifth with a major international carrier and its first with a foreign airline.
• Renewed an Essential Air Service contract in Kalaupapa, Hawaii, valued at $9.9 million over four years.
• Continued investment in interior and exterior fleet refurbishment to enhance reliability and passenger experience.

Recalibrating the On Demand Business

• Third quarter revenue increased approximately 40% compared to both the second quarter and the same quarter in the prior year driven by:
  • An increase in average revenue per departure of 14%
  • A shift in mix from turboprop to larger aircraft, and
  • A shift in mix from domestic to international flights
• The results reflect SRFM’s strategies to expand our client base from turboprop to jet aircraft and pursue international markets
• On Demand margins for the third quarter, while slightly lower than the second quarter, represented significant improvement from the same quarter of the prior year, benefiting from the successful execution of two volume purchase agreements with operators who are also beta users of SurfOS

Driving Efficiencies with SurfOS

• Addition of beta and LOI SurfOS agreements, totaling 15 agreements
• BrokerOS developments:
  • Developed robust CRM functionality that allows for streamlined customer insights and sales efficiencies, to include:
    • A broker dashboard providing key metrics to manage flights and sales
    • An activity feed consolidating all account interactions in a single timeline view
    • Multimodal direct-to-operator communication via e-mail and SMS
    • Account properties to track profiles and behaviors for better consumer insights and pipeline management

‍

With measurable progress now showing across both operations and software deployment, leadership’s confidence in the company’s long-term direction has seemed to only grow stronger.

Last year, Co-Founder and Director Sudhin Shahani purchased over 400,000 shares of company stock, a transaction valued at roughly $1 million. The purchase suggests insider conviction in Surf Air Mobility’s transformation strategy and its momentum heading into the next phase of growth.

And that momentum isn’t slowing down.

Surf Air Mobility recently signed a five-year software licensing agreement with Palantir, giving it exclusive rights to configure and sell SurfOS to Part 135 charter operators and brokers. The agreement also allows the companies to jointly pursue development projects for operators, manufacturers, and even the FAA, a strong validation of Surf Air Mobility’s growing footprint in aviation software.

To complement this progress, the company also renewed another long-term Essential Air Service contract in Hawaii valued at $4.2 million.

These milestones make one thing clear: Surf Air Mobility is no longer an early-stage story. It’s executing and using real technology to reshape an overlooked corner of the aviation market.

With more catalysts ahead and third-quarter results on the horizon, this is a story worth keeping on the radar.

Our Top Reasons to Research This One

• Stonegate Capital Partners Updates Coverage On Surf Air Mobility Inc. With $7.05 Mid-Point Target: Stonegate Capital Partners’ analyst, Dave Storm, provided an updated report on (NYSE: SRFM). In it, he came to the conclusion (NYSE: SRFM) deserved a $7.05 mid-point target.
  From its closing valuation on Thursday, this target is (NYSE: SRFM) 125+% from current prices.
• Surf Air Mobility Strengthens AI Aviation Future With SurfOS Expansion: Surf Air Mobility advances SurfOS development with $26Mn in dedicated funding from its recent $100Mn strategic transaction, expanding AI-enabled aviation software powered by Palantir.
• The company is projecting a 2026 commercial rollout of SurfOS flagship products, highlighting early operational success and stronger Palantir collaboration to enhance efficiency and pro-fit-ability across private aviation and regional air mobility.
• Expanding SurfOS Partnerships To Revolutionize Aviation Efficiency And Pro-fit-ability: Surf Air Mobility Inc. announced LOI agreements for its SurfOS software, expanding adoption across brokers, regional, cargo, and charter operators. Powered by Palantir AI, SurfOS aims to unify aviation data, boost efficiency, and drive pro-fit-ability.‍
• Palantir Veteran Joins Surf Air Mobility’s Board: Surf Air Mobility recently appointed Shawn Pelsinger to its Board of Directors, the former Global Head of Corporate Development & Senior Counsel at Palantir Technologies (NASDAQ: PLTR). Pelsinger helped forge the 2021 partnership between Surf Air Mobility and Palantir and led major deals with Airbus (Skywise), HD Hyundai, and Credit Suisse. His addition further strengthens the Palantir–Surf Air Mobility connection as the company scales its SurfOS™ platform across the air mobility industry.
• Momentous Market Expansion: The global regional air mobility market is anticipated to expand to $75 to $115Bn by 2035, and Surf Air Mobility Inc. (NYSE: SRFM) is aligning with this industry growth trajectory.
• Company Unveils Flagship Software Products: Introducing its flagship SurfOS AI-enabled operating system positions Surf Air Mobility as a leader in aviation by unifying industry data to improve efficiency and increase pro-fit-ability. SurfOS will integrate industry data into a single, federated platform, creating an operating system for the Air Mobility industry powered by Palantir Technologies (NASDAQ: PLTR).
• Another Analyst Target Suggests Triple-Digit Upside Potential: Back in March of 2025, H.C. Wainwright analyst, Amit Dayal, initiated coverage on Surf Air Mobility Inc. (NYSE:SRFM) with a price forecast of $12.

Surf Air Mobility Partners with the Hawaii Department of Transportation and BETA Technologies to Advance Electric Aviation in Hawaii with eIPP Application

Surf Air Mobility (NYSE: SRFM) will leverage Mokulele Airlines’ Hawaii network and SurfOS software with BETA Technologies’ (NYSE: BETA) ALIA electric aircraft to enable near-term electric air service supporting HDOT’s transportation and sustainability goals.

Surf Air Mobility is building a scalable Advanced Air Mobility platform grounded in real-world airline operations, safety, community connectivity, and software.

Surf Air Mobility’s Mokulele Airlines subsidiary is the largest commuter airline in Hawaii, making it uniquely positioned to support the launch of next-generation electric aircraft into commercial service.

LOS ANGELES–(BUSINESS WIRE)– Surf Air Mobility Inc. (NYSE: SRFM) (“Surf Air Mobility” or the “Company”), a leading air mobility platform, today announced it has partnered with the Hawaii Department of Transportation (“HDOT”) and electric aerospace company, BETA Technologies (NYSE: BETA) (“BETA”), on the request for proposal (“RFP”) application for the Electric Vertical Takeoff and Landing Integration Pilot Program (“eIPP”), a federal public-private initiative within the White House’s Advanced Air Mobility (“AAM”) National Strategy.

Surf Air Mobility believes its existing operational footprint in Hawaii is an ideal launch market for AAM aircraft. The Company’s airline subsidiary, Mokulele Airlines (“Mokulele”), is the largest commuter airline in Hawaii by scheduled departures, providing high-frequency interisland service across 10 routes and nine destinations. With established airport operations, maintenance facilities, and crew based across Hawaii, Surf Air Mobility has built the foundation to safely and efficiently integrate electric aircraft into existing commercial airline service, an approach that aligns directly with the eIPP RFP’s objectives.

In coordination with HDOT and BETA, Surf Air Mobility would bring together its airline operations, safety culture, SurfOS software, and community connectivity together with BETA’s electric aircraft technology, making it an ideal candidate for the eIPP initiative. BETA’s ALIA electric aircraft is designed for short-haul routes like those flown daily by Mokulele Airlines, creating a practical pathway for electrification within Hawaii’s existing air transportation system. The entities initially plan to conduct cargo-carrying missions between Mokulele’s existing route pairs.

Mokulele Airlines Operational Highlights:

• Operates the largest airline network in Hawaii by airports served and has the most scheduled departures among commuter airlines in Hawaii
• Has operated, in aggregate, tens of millions of revenue passenger miles with proven interisland expertise
• Flew approximately 36,000 flights in 2025, with an average flight length of 51 miles, an ideal length for the first generation of electrified aircraft
• Flew approximately 224,000 passengers in 2025, serving a high percentage of repeat and local fliers
• Achieved 96% controllable completion factor1
• Employs 196 people in Hawaii, including 96 pilots
• Maintains a strong safety record and certification under FAA Part 135 operations
• Has three maintenance centers located in Honolulu (HNL), Kahului (OGG), and Kona (KOA)
• Provides Essential Air Service connecting underserved island communities
• Has interline agreements with major commercial airlines, including: Hawaiian, Alaska, American, United, and Japan Airlines

BETA’s electric aircraft, ALIA, has flown more than 100,000 nautical miles in real-world operations, generating operational data that supports a disciplined certification-aligned roadmap.

Ed Sniffen, Hawaii Department of Transportation Director, said: “The eIPP initiative would provide an opportunity for Hawaii to be at the forefront of advanced aviation mobility technology, while supporting the Hawaii Department of Transportation’s long-term efforts to develop efficient, affordable, and renewable alternative forms of interisland transportation.”

Deanna White, CEO of Surf Air Mobility, said: “As Hawaii’s largest commuter airline flying approximately 100 flights daily, we understand the routes and operational realities. Our infrastructure is perfectly suited to introduce next-generation aircraft. Participating in the eIPP initiative with BETA would support Hawaii’s leadership in advanced air mobility while delivering quieter, lower-emission transportation for communities and visitors.”

Kristen Costello, Head of Government and Regulatory Affairs at BETA Technologies, said “Hawaii is exactly the kind of operating environment electric aviation was built to serve. Short, high-frequency routes, strong community connectivity, and a real need for reliable, affordable interisland service make this a natural early market for electrification. Working with Surf Air Mobility and HDOT through the eIPP allows us to demonstrate how electric aircraft can improve access, lower operating costs, and integrate safely into existing airline operations, and deliver real benefits to communities from day one.”

If selected, the eIPP initiative would support additional infrastructure development, operational readiness, and early deployment of electric aircraft in Hawaii, further advancing AAM through real-world airline operations.

With momentum building across operations, technology, and partnerships, Surf Air Mobility (NYSE:SRFM) remains one of the most compelling regional aviation stories to watch heading into year-end.

Remember to do your own research.

NEWS

Surf Air Mobility Partners with the Hawaii Department of Transportation and BETA Technologies to Advance Electric Aviation in Hawaii with eIPP Application

Jan 27, 2026

Surf Air Mobility Builds Foundation for Advanced Air Mobility by Investing in Mokulele Airlines’ Hawaii Operations

Jan 22, 2026

Surf Air Mobility to Attend the 28th Annual Needham Growth Conference

Jan 8, 2026

Surf Air Mobility Advances SurfOS Development, Targets Commercial Software Rollout in 2026, and Reports Milestones

Dec 30, 2025

Surf Air Mobility to Present at the H.C. Wainwright AeroNext: Investing in Advanced Air Mobility, Urban Aviation, and Unmanned Systems Virtual Conference

Dec 1, 2025

Stonegate Capital Partners Updates Coverage On Surf Air Mobility Inc. (SRFM) 2025 Q3

Nov 13, 2025

Surf Air Mobility Reports Third Quarter 2025 Financial Results, Exceeding Revenue and Meeting Adjusted EBITDA Guidance

Nov 12, 2025

Surf Air Mobility Announces $100 Million Strategic Transaction to Accelerate Growth and Strengthen Balance Sheet

Nov 10, 2025

Surf Air Mobility to Announce Third Quarter 2025 Financial Results on November 12, 2025

Oct 30, 2025

Surf Air Mobility Appoints Shawn Pelsinger to Board of Directors

Oct 8, 2025

‍

Designed to connect key stakeholders into a single, unified ecosystem, SurfOS is our AI-enabled operating system built to make the private aviation and air mobility industries more efficient, intelligent, and ready for the future.

Learn more at https://t.co/QwxL6iiGCx pic.twitter.com/2lb6xJ9I4H

— Surf Air (@SurfAir) December 31, 2025

MANAGEMENT TEAM

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF FIFTEEN THOUSAND USD BY LFG EQUITIES CORP FOR A ONE DAY SRFM AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

****Sponsored by LFG Equities Corp

‍

SER founders developed the first-generation of “PEGylated” drugs, which became the standard for delivery of protein drugs and has enabled 30 FDA approved products that have since generated over $140B in cumulative sales

Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for theTreatment of Advanced Parkinson’s disease

SER has a Float of Roughly 5.3 Million According to the Leading Charting Site Finviz

Check Out the Investor Presentation Here‍

Hello Everyone,

We are back with something we want you to research and take a look at during today’s session.

According to all of my research, this one has a TINY float of just about 5.3 million according to Finviz. With only 10M outstanding and 47% insider ownership, this one has an extremely favorable structure right now. Several market dynamics add to the story. Trading activity in this one has the potential to be amplified under the right conditions. Layer in a pair of notable analyst price targets and a stream of recent corporate updates pointing to developmental progress, and it becomes evident why this NYSE American-listed biotech has started drawing attention.

Pull up SER right away.

With a focus on next-generation molecules, their work spans diverse central nervous system disorders and beyond.

SER has ongoing collaborations with specialized partners that support the exploration of novel RNA-based medicines targeting vaccine immunology, cancer immunotherapy, and gene therapy.

This forward-thinking approach to drug discovery highlights a commitment to unlocking new possibilities in medicine, making the company well worth closer attention for those interested in emerging therapeutic frontiers.

This one has an interesting story behind it. The founders already did it once. This company was founded in 2007 and was largely funded by the founders and certain investors who followed the team to Serina after the successful exit (via acquisition by Nektar Therapeutics) of the founding team’s prior company, Shearwater Polymers.

At Shearwater, Serina co-founders Dr. Milton Harris and Dr. Michael Bentley developed the first-generation of “PEGylated” drugs. PEG (polyethylene glycol) technology became the standard for delivery of protein drugs and has enabled 30 FDA approved products that have since generated over $140B in cumulative sales. Serina was founded to engineer a next generation polymer therapeutic (our POZ PlatformTM) to address the limitations of PEG and other biocompatible polymer technologies — enabling new treatment paradigms for patients suffering from some of the world’s most challenging diseases.

Serina Therapeutics’ proprietary POZ platform is built on a synthetic, water-soluble, low-viscosity polymer known as poly (2-oxazoline).

During the synthesis process, a precise amount of drug is incorporated onto the polymer backbone using pendant alkyne groups and metal-catalyzed “click chemistry.”

This POZ technology enables enhanced control over drug loading and allows for more precise management of drug release rates.As a result, drugs with narrow therapeutic windows can be engineered to maintain more desirable and stable blood concentrations.

While optimized for small molecules, the platform is also applicable to proteins, aptamers, and other classes of molecules.

Serina Therapeutics is building a pipeline centered on next-generation compounds aimed at treating central nervous system disorders, while also extending its reach into broader therapeutic categories. Through partnerships with specialized research groups, the company is exploring RNA-based technologies with applications spanning vaccine science, oncology immunotherapy, and gene therapy.

The overarching objective is ambitious but clear: to push the boundaries of what modern drug design and delivery can achieve.

Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for theTreatment of Advanced Parkinson’s disease

– Phase 1b clinical site start-up and regulatory activities in Australia underway tosupport the global registrational program

-HUNTSVILLE, AL, Jan 28, 2026 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina” orthe “Company”) (NYSE American: SER), a clinical-stage biotechnology company advancingdrug candidates enabled by its proprietary POZ PlatformTM drug optimization technology,today announced that the U.S. Food and Drug Administration (FDA) has cleared itsInvestigational New Drug (IND) application for SER-252, an investigational therapy for advanced Parkinson’s disease.The IND clearance allows Serina to proceed with regulatory and site-level activities to support initiation of a planned Phase 1b registrational clinical study evaluating SER-252 inpatients with advanced Parkinson’s disease.“FDA clearance of the IND is a major milestone for Serina and underscores the promise of the SER-252 program,” said Steve Ledger, Chief Executive Officer of Serina Therapeutics. “As we initiate our registrational study, we will begin generating meaningful clinical data for SER252 in patients with advanced Parkinson’s disease. With FDA alignment on a registrational development strategy under a 505(b)(2) NDA pathway, we believe SER-252 has a clear andefficient path forward toward addressing a significant unmet medical need.”As previously disclosed, Serina has engaged in multiple regulatory interactions with the FDAregarding the SER-252 program, including receipt of written FDA feedback supporting the proposed registrational clinical trial design under a 505(b)(2) NDA pathway.

Platform Science: A Polymer-Based Approach

At the center of Serina’s strategy is its proprietary poly(2-oxazoline) (POZ) polymer technology. This synthetic, water-soluble polymer allows drug molecules to be chemically linked along a controllable backbone using precision “click chemistry.” The result is tighter control over how much drug is attached and how quickly it is released once administered.

This level of control is especially relevant for therapies with narrow therapeutic windows, where maintaining stable blood concentrations can be critical to both efficacy and safety. While initially optimized for small molecules, the platform is adaptable to biologics, nucleic acids, and other advanced therapeutic classes.

Differentiation from PEG

POZ is positioned as a next-generation alternative to polyethylene glycol (PEG), a commonly used drug-delivery polymer. One of PEG’s known limitations is the potential for immune responses and antibody formation in some patients. POZ is engineered to reduce this immunogenicity risk while preserving favorable drug-delivery properties.

Why Sustained Delivery Matters in Neurology

Neurological treatments — including those for Parkinson’s disease — often require frequent dosing because drug levels rise and fall quickly in the bloodstream. These fluctuations can lead to variable symptom control, increased monitoring needs, and challenges with adherence and quality of life.

Serina’s platform is designed to address this by enabling longer-acting, subcutaneous formulations that release medication gradually, potentially smoothing out those peaks and troughs.

Pipeline Focus

Serina’s lead candidate, SER-252, targets advanced Parkinson’s disease. The therapy is intended to deliver sustained dopaminergic stimulation through extended drug release, with clinical trials anticipated to begin in 2025.

Beyond Parkinson’s, the company continues to evaluate additional CNS indications and maintains platform collaborations exploring RNA-based therapeutics for immunology and gene-related applications.

In sum, Serina Therapeutics represents an early-stage biotech story built around a differentiated drug-delivery platform, a neurology-focused pipeline, and multiple upcoming development milestones. The combination of scientific ambition, clinical progress, and market structure dynamics explains why the company has emerged as a name of interest among speculative biotech watchers.

POZ Delivers Key Advantages

POZ is engineered to address the limitations of PEG (polyethylene glycol) and other biocompatible polymers – such as immunogenicity, where unlike PEG, POZ does not elicit an immune response or stimulate development of antibodies to the polymer itself.

Enabling Continuous Drug Delivery

Many drugs, for example those used to treat neurological disorders like Parkinson’s, have narrow therapeutic ranges in which they can work safely and efficaciously.

They are often dosed more frequently – resulting in large and frequent fluctuations in drug exposure.

They have to be monitored and dose adjusted with greater frequency, and on an individual basis.

These fluctuations present clinical, compliance and quality of life challenges for many patients.

Administered Subcutaneously, POZ Provides Extended Delivery

Serina is in the process of developing proprietary drugs to treat neurological diseases. Their lead product candidate, SER-252 for advanced Parkinsons Disease, is anticipated to enter clinical trials in 2025. Their current discovery and development work includes a focus on unlocking the potential of cannabinoids and other molecules across a range of CNS indications and beyond. Their POZ platform partners are at the forefront in advancing novel RNA medicines in vaccine immunology, cancer immunoRX, and gene therapy.

Their proprietary POZ platform technology has been designed for programmable, targeted delivery of a broad range of small molecules. The technology has been clinically demonstrated to safely enable continuous drug delivery via a once weekly subcutaneous injection. The POZ platform is customizable, versatile and can be Serina is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina’s POZ PlatformTM provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs).

The technology is based on a synthetic, water soluble, low viscosity polymer called poly(2-oxazoline). Serina’s POZ technology is engineered to provide greater control in drug loading and more precision in the rate of release of attached drugs delivered via subcutaneous injection. The therapeutic agents in Serina’s product candidates are typically well-understood and marketed drugs that are effective but are limited by pharmacokinetic profiles that can include toxicity, side effects and short half-life. Serina believes that by using POZ technology, drugs with narrow therapeutic windows can be designed to maintain more desirable and stable levels in the blood.

Serina’s POZ platform delivery technology has potential for use across a broad range of payloads and indications. Serina intends to advance additional applications of the POZ platform via out-licensing, co-development, or other partnership arrangements, including the non-exclusive license agreement with Pfizer, Inc. to use Serina’s POZ polymer technology for use in lipid nanoparticle drug (LNP) delivery formulations.

About SER-252 (POZ-apomorphine)

SER 252 is an investigational apomorphine therapy developed with Serina’s POZ platform and designed to provide continuous dopaminergic stimulation (CDS). CDS has been shown to reduce the severity of levodopa-related motor complications (dyskinesia) in Parkinson’s disease. Preclinical studies support the potential of SER 252 to provide CDS without skin reactions. Serina plans to advance SER 252 to clinical testing in 2025.

Their proprietary POZ platform is based on a synthetic, water soluble, low viscosity polymer called poly (2-oxazoline). During the synthesis steps, a predictable amount of drug is incorporated on the backbone of the polymer using pendant alkyne groups and metal catalyzed “click chemistry”.

POZ technology provides greater control in drug loading, and the rate of release of attached drugs can often be more precisely controlled. Drugs with narrow therapeutic windows can be designed to maintain more desirable and stable levels in the blood. The technology is optimized for small molecules and can also be applied to proteins, aptamers and other classes of molecules.

‍

Their largest shareholder, Juvenescence Ltd. recently secured $150 million in Series B financing led by M42, a global tech-enables health company headquartered in Abu Dhabi.

This significant investment and accompanying strategic alliance will accelerate Juvenescence’s mission to develop innovative therapies targeting age-related diseases and extending healthspan. As part of this partnership, Juvenescence and M42 will launch a drug development hub in Abu Dhabi, combining AI-enabled drug discovery with cutting-edge data and clinical infrastructure to speed the development of novel therapeutics.

Juvenescence has been a critical partner to Serina, providing strategic guidance and capital that has helped them advance their POZ Platform™ into the clinic.

RECENT HIGHLIGHTS

• 
  Regulatory Update: SER-252 for Advanced Parkinson’s Disease: Following a Type B meeting with the U.S. Food and Drug Administration (the “FDA”) in August 2025, the FDA’s written feedback supported Serina’s proposal to advance SER-252 under a 505(b)(2) NDA pathway for advanced Parkinson’s disease. On November 3, 2025, the FDA placed the IND on clinical hold pending additional information regarding a commonly used formulation excipient. The hold does not relate to the active drug substance or its mechanism of action. Serina expects the formal FDA communication within 30 days and is actively working to address the FDA’s questions to enable the initiation of the registrational study as soon as possible.
• Advancement of SER-270 for Tardive Dyskinesia: Serina continues to advance SER-270, its next program from the POZ Platform, designed to deliver long-acting VMAT2 inhibition for the treatment of tardive dyskinesia (TD). The Company is on track to complete formulation optimization and pre-IND activities in 2026.
• Secured Up to $20 Million in Funding: In September 2025, Serina entered into a convertible note and warrant financing agreement providing up to $20 million in funding, led by a member of Serina’s Board of Directors. The first $5 million tranche was drawn in September. If all warrants are issued and exercised in full, the financing could yield additional gross proceeds of up to $20 million.
• Expanded Stakeholder Communications and Transparency Initiatives: In October 2025, Serina launched a comprehensive corporate communications platform to enhance stakeholder engagement and transparency. The initiative includes regular digital updates, educational content, multimedia resources, and expert commentary aimed at patients, clinicians, investors, and the scientific community.
• At-the-Market (ATM) Equity Program: In April 2025, Serina entered into a Capital on Demand™ Sales Agreement with JonesTrading Institutional Services LLC, under which the Company may offer and sell up to $13.3 million of common stock. As of November 7, 2025, Serina has issued 474,712 shares of common stock at a gross average price of $6.00, resulting in net proceeds of $2.8 million.

‍

NEWS

Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event

7 hours ago

Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders’ Equity

Jan 15, 2026

Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry

Dec 11, 2025

Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program

Dec 10, 2025

Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

Nov 13, 2025

Serina Therapeutics Provides Regulatory Update on SER-252 Program

Nov 3, 2025

Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors

Oct 8, 2025

Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Disease

Oct 6, 2025

Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease

Sep 9, 2025

Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025

Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disease under 505(b)(2) NDA Pathway

Aug 25, 2025

Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights

Aug 11, 2025

Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD)

Jul 29, 2025

Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference

Jul 28, 2025

Serina Therapeutics Makes Grant to New Employee Under Inducement Plan

Jul 10, 2025

Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting

Jul 1, 2025

Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025

Jun 23, 2025

UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42

Jun 17, 2025

Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42

Jun 17, 2025

Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event “Is the Beaten Down Biotech Sector the Smartest Bet in Today’s Volatile Market?”

Jun 9, 2025

MANAGEMENT

‍

Simba Gill, Ph.D.

Executive Chairman

Simba has a wealth of biotech and pharma experience in building companies and transformative platforms as well as developing products, having served in key executive roles at Maxygen, Systemix, Boehringer Mannheim and Celltech over his thirty-year career.  He has served as a partner and advisor at Flagship Pioneering where he was the founding CEO of Evelo Biosciences and as a Venture Partner at TPG where he was Founder CEO of Moksh8 Pharmaceuticals. Simba is currently a board member at Foghorn Therapeutics (NASDAQ – FHTX) and Sensorium Therapeutics. He earned his MBA at INSEAD and received his Ph.D. from King’s College, London.

‍

Steve Ledger

CEO and Director

Steve has served as CEO since March 2024 and CFO from March 2022 to March 2024. He has more than 35 years of experience as an investor, board member, advisor, and in operational roles with early-stage companies. He is a General Partner of Form & Fiction Ventures (FFV), a venture studio that launches and invests in startup and seed stage companies focused on socially responsible initiatives. He has served in investment management roles at Caldwell Sutter Capital, Tamalpais Partners, SF Sentry Securities, Kayne Anderson, and Fidelity Investments. Mr. Ledger received a B.A. in Economics from the University of Connecticut.

Randall

Randall Moreadith, M.D., Ph.D.

Chief Development Officer

Randall has served as Serina’s CDO since March 2024. He served as Serina’s President, CEO, and member of Serina’s board of directors from September 2010 to March 2024. Prior to Serina, Randall served in executive leadership roles including CDO at Nektar Therapeutics, CMO of Cardium Therapeutics, CMO at Renovis, and President / co-Founder of ThromboGenics (now Oxurion). Dr. Moreadith received his M.D. from Duke University and is trained clinically in Internal Medicine and Cardiovascular Diseases. Following his Fellowship in Cardiology at Duke University, he joined the laboratory of Professor Philip Leder where he was a Howard Hughes Medical Institute Fellow in Genetics at Harvard Medical School. Dr. Moreadith received his Ph.D. from Johns Hopkins University.

‍

Greg Curhan

CFO

Greg joined Serina as CFO in August 2024. He has over 35 years of operational, financial, capital markets and strategic advisory experience in various sectors including Investment Banking and Medical Device/Life Sciences. Greg has been a Partner at FLG Partners since 2020. Also since 2020, Greg has served as the CFO for Curevo Vaccines, a private biotech company focused on infectious disease immunology. As CFO, Greg has managed Finance, Legal, HR, and Investor Relations functions for Public and Private companies. He has raised equity and debt capital for both private and public companies, completed numerous successful IPOs, and executed M&A transactions, both acquiring and divesting companies. He has also served in CEO, President and Board of Director capacities. Greg earned a BA degree in Economics from Dartmouth College.

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF FIFTEEN THOUSAND USD BY LFG EQUITIES CORP FOR A ONE DAY SER AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.

*Sponsored by Primetime Profiles, LLC

Smartkem Partners with AUO to develop the world’s first rollable, transparent MicroLED display – the first display in production using Smartkem’s technology

The company has an extensive IP portfolio including 140 granted patents across 17 patent families, 14 pending patents and 40 codified trade secrets.

SMTK has entered into multiple strategic collaborations and agreements with industry-leading display manufacturers in Asia, North America, and Europe

Smartkem Signs Letter of Intent with Carbonium Core, Inc. to Expand Advanced Materials Portfolio into Nuclear-Grade Graphite

READ THE INVESTOR PRESENTATION HERE

‍

____________________

‍

Hello Everyone,

‍

We have something that we wanted to bring to your attention for today’s session. This one has been beat up a little bit over the past few weeks but the potential to bounce is strong after yesterdays drop. This could be the perfect time to have SMTK on your radar.

If you have been a member for a while then you should remember SMTK as it was one of our biggest profiles of 2024.

We brought SMTK to your attention way back then when we saw it open up at $3.91 an jump the next day to $10.95 for a potential 180% move. That was a while ago and a lot has changed for SMTK.

Smartkem is seeking to reshape the world of electronics with its disruptive organic thin-film transistors (OTFTs) that have the potential to revolutionize the display industry.  

In seeking to enable the adoption and mass commercialization of next generation MicroLED displays, Smartkem’s low temperature (80°C) process allows its liquid transistors to be poured directly onto the MicroLEDs, eliminating many of the high-cost, low-yield manufacturing processes used in traditional production.

This innovation reduces defects, enhances yield and integrates seamlessly into existing manufacturing processes, making MicroLED displays more commercially viable across sectors including smartphones, wearables, automotives and digital signage.

Smartkem develops its materials at its research and development facility in Manchester, UK and provides prototyping services at the Centre for Process Innovation (CPI) at Sedgefield, UK. It has a field application office in Taiwan. The company has an extensive IP portfolio including 138 granted patents across 17 patent families, 16 pending patents and 40 codified trade secrets.

‍

SMTK has entered into a number of joint agreements with outside companies, including:

• February 2024: Shanghai-based Tianma Microelectronics “to integrate Smartkem’s Organic Thin-Film Transistor (OTFT) technology with Tianma’s oxide transistors to develop OTFT-based microarray biochips.”

• March 2024: Taiwan-based RiTdisplay “for the manufacture of a new type of active-matrix OLED (AMOLED) display.”
• March 2024: The Industrial Technology Research Institute (ITRI) in Taiwan to enable customers access to product prototyping on its Gen2.5 line using Smartkem’s OTFT technology.

• September 2024: Shanghai-based Chip Foundation “to co-develop a new generation of microLED-based backlight technology for Liquid Crystal Displays.”
• November 2024: Smartkem and AUO Partner to Develop a New Generation of Rollable, Transparent MicroLED Displays
• December 2024: Smartkem Signs Multi-Year Agreement with FlexiIC to Develop a New Generation of CMOS for Smart Sensors
• March 2025: Signed MOU with RiTdisplay to Integrate Smartkem’s OTFT process onto its Gen2.5 Line to commercialize the next generation of AMOLED displays using OTFT technology
• May 2025: Announced collaboration with Manz Asia, a “developer of production solutions for semiconductor advanced packaging manufacturing sectors” that “includes the demonstration of inkjet printable dielectric layers for use in advanced computer and AI chip packaging solutions.”
• January 2025: Signed proof-of-concept agreement with “a global consumer electronics leader” to “develop next-generation smart wearables that incorporate a conformable MicroLED display utilizing Smartkem’s proprietary organic thin-film transistor (OTFT) technology.” [emphasis added]

Dr. Maosheng Hao, chairman of Chip Foundation, said:

“Smartkem is widely recognized as a leading provider of OTFT solutions, with deep expertise and extensive experience in organic dielectric materials, organic semiconductor materials, and related processes. ….

“We believe that this collaboration between our two companies has the potential to expedite the advancement and widespread adoption of this technology by the display industry.”

Those are just a few key agreements. If you check out the companies website and news feed you are going to find several more.

Using its TRUFLEX® organic semiconductor and dielectric inks, or liquid polymers, Smartkem has developed a complete six-layer transistor stack and fabrication process. Smartkem’s core chemistry enables its electronic polymers to be processed at temperatures as low as 80^oC, which by electronic industry standards is very low. The inks are solution deposited, onto low-cost plastic or glass substrates.

Breakthrough Technology

The TRUFLEX® materials stack is a breakthrough technology comprising six individually designed material formulations encompassing every layer in the device, starting from the initial planarising base layer, all the way through to the final passivation layer chemistry. The ink set includes the active organic semiconductor material and a series of orthogonal passive interlayer inks (Base layer, Self-Assembled Monolayer, Organic Gate Insulator, Sputter Resistant Layer and Passivation layer). Smartkem’s proprietary materials set is covered by an extensive IP portfolio comprising 125 granted patents across 19 patent families and 40 codified trade secrets.

‍

Smartkem Signs Letter of Intent with Carbonium Core, Inc. to Expand Advanced Materials Portfolio into Nuclear-Grade Graphite

MANCHESTER, United Kingdom, Feb. 02, 2026 (GLOBE NEWSWIRE) — Smartkem, Inc. (Nasdaq: SMTK), (“Smartkem”), a developer of advanced materials, today announced that it has entered into a non-binding letter of intent (“LOI”) to acquire 100% of the outstanding shares of Carbonium Core, Inc., a U.S.-based advanced materials company focused on the production of nuclear-grade graphite for advanced reactor technologies.

In connection with this transaction, Smartkem has mutually agreed to terminate its previously announced LOI with Jericho Energy Ventures, with no penalties or disputes arising from the termination. The Company views this transaction as a strategic progression aligned with its long-term materials roadmap.

Under the terms of the LOI, Smartkem intends to acquire all outstanding shares of Carbonium Core, Inc. in exchange for shares of Smartkem Series B Convertible Preferred Stock, subject to the execution of definitive agreements, completion of due diligence, and customary closing conditions. The LOI includes a customary exclusivity period and is non-binding with respect to the consummation of the proposed transaction.

Strategic Fit and Materials Capability Alignment

Carbonium Core, Inc. is a U.S.-based developer of nuclear-grade graphite for advanced reactor systems, focused on converting domestically sourced carbon feedstock into reactor-qualified graphite through fully U.S.-based processing and manufacturing. The proposed transaction combines Smartkem’s materials chemistry and manufacturing scale-up capabilities with Carbonium Core, Inc.’s vertically integrated domestic production platform to establish a secure, U.S.-controlled supply chain for a critical nuclear material, reduce reliance on foreign-controlled sources, and directly support national energy security, supply-chain resilience, and advanced nuclear deployment objectives.

Leadership Commentary

“This transaction would expand our materials portfolio into a new and exciting market,” said Ian Jenks, Chairman and Chief Executive Officer of Smartkem. “We believe that nuclear-grade graphite is a strategically critical market with significant technical complexity and long-term demand drivers. Carbonium Core, Inc.’s capabilities align strongly with our ambition to build differentiated, high-value materials platforms that address global supply-chain challenges.”

“Being one of the first domestic companies to take coal all the way to nuclear-grade graphite is a milestone for Carbonium Core, Inc. and for the U.S. It proves that advanced materials, once thought to be imported necessities, can be engineered domestically with precision, responsibility, and vision,” added Suren Ajjarapu, Chief Executive Officer of Carbonium Core, Inc. “Smartkem is a world-class advanced materials company that brings deep expertise and process innovation, and we believe this combination can accelerate our mission to deliver a secure, domestic supply of nuclear-grade graphite for the next generation of U.S. reactor technologies.”

Proposed Transaction Highlights

• Expansion into a Critical New End Market: The proposed transaction is intended to expand Smartkem’s advanced materials portfolio into nuclear-grade graphite, a strategically critical material required for next-generation nuclear reactor technologies.
• Alignment with Long-Term Energy and Industrial Trends: Advanced nuclear is expected to play a growing role in energy security and decarbonisation, driving sustained demand for high-performance, reactor-qualified materials with long qualification cycles and high barriers to entry.
• Strong Technical and Manufacturing Fit: Management believes that Carbonium Core, Inc.’s graphite purification and processing capabilities are highly complementary to Smartkem’s expertise in materials engineering, process integration, and manufacturing scale-up.
• Domestic Supply Chain Opportunity: The combination is intended to support the development of a secure, U.S.-based supply chain for nuclear-grade graphite, reducing reliance on foreign sources for a strategically sensitive material.
• Portfolio Diversification with Technical Continuity: The proposed transaction represents a logical extension of Smartkem’s core competencies into a new market with attractive technical complexity and long-term commercial potential.

Terms of the Proposed Transaction

Smartkem has signed a non-binding letter of intent to acquire 100% of the outstanding shares of Carbonium Core, Inc.

The proposed transaction contemplates aggregate consideration to be paid by Smartkem to Carbonium Core shall consist of newly created Series B Convertible Preferred Stock of SmartKem having an aggregate stated and liquidation value of $120,000,000 (the “Preferred Stock Consideration”), which Preferred Stock Consideration shall be issued as follows:

• 50% of the Preferred Stock Consideration shall be issued at Closing; and
• The remaining 50% of the Preferred Stock Consideration shall be issued upon the Company achieving certain milestones to be defined in the definitive agreement.

The Series B Convertible Preferred Stock shall be convertible into such number of shares of Common Stock of the Smartkem as is determined by dividing the Preferred Stock Consideration by $1.00 per share.

The Series B Convertible Preferred Stock shall not have any voting rights.

The Series B Convertible Preferred Stock shall be convertible, at any time commencing after the six (6) month anniversary of the Closing Date, into such number of shares of Common Stock of Smartkem as is determined by dividing the Preferred Stock Consideration by $1.00 per share.

The Series B Convertible Preferred Stock shall contain beneficial ownership limitations such that each holder and its affiliates shall not be able to convert the Series B Convertible Preferred Stock into more than 4.99% of Smartkem’s Common Stock and it will not be exercisable into Smartkem’s Common Stock until the date on which any stockholder approval is obtained in accordance with the rules of the NASDAQ Stock Market (“Stockholder Approval”).

The parties currently anticipate completing the proposed transaction on or before February 5, 2026, subject to extension by mutual agreement. Carbonium Core, Inc. has agreed to a 90-day exclusivity period, during which it will not solicit or engage in discussions regarding alternative transactions. Completion of the proposed transaction is subject to satisfactory due diligence, execution of definitive agreements, receipt of required approvals, and other customary closing conditions. There can be no assurance that any definitive agreements will be negotiated or executed, that the proposed transaction will be consummated on the terms described herein, or at all, or as to the timing or final terms of any transaction.

Following the completion of the proposed transaction, Smartkem’s board of directors is expected to consist of five members, with two appointed by Carbonium Core, Inc. and three by Smartkem, subject to definitive documentation and stockholder approval in accordance with the rules and regulations of the NASDAQ Stock Market.

Either party may terminate the LOI under customary circumstances, including failure to complete due diligence or by mutual written consent, without the imposition of any break-up fees.

E.F. Hutton & Co. is serving as exclusive M&A advisor to Smartkem.

Smartkem Signs Proof of Concept Agreement with Global Consumer Electronics Giant for MicroLED Wearables

Agreement marks validation of Smartkem’s transistor technology and could lead to the introduction of a novel MicroLED display architecture to the smart wearables market

MANCHESTER, England, Jan. 06, 2026 (GLOBE NEWSWIRE) — Smartkem, Inc. (Nasdaq: SMTK), a company developing a new class of organic semiconductor technology, today announced that it has entered into a 12-month paid proof-of-concept agreement with a global consumer electronics leader to develop next-generation smart wearables that incorporate a conformable MicroLED display utilizing Smartkem’s proprietary organic thin-film transistor (OTFT) technology.

The collaboration is expected to develop curved surface wearable devices built around OTFT-based MicroLED display technology that addresses some of the most difficult challenges in wearables: extreme miniaturization, low power consumption, outdoor visibility and high impact resistance. The program will integrate Smartkem’s proprietary OTFT technology with MicroLEDs using its “chip-first” architecture to address one of the smallest and most demanding form factors in consumer electronics.

“This agreement validates industry interest in Smartkem’s technology and, if successful, moves Smartkem beyond platform validation and into product-level execution for wearable devices,” said Ian Jenks, Chairman and Chief Executive Officer of Smartkem. “Compact wearables are among the most demanding form factors in consumer electronics, and MicroLED is increasingly recognized as the technology best suited to deliver the high brightness and efficiency they require.”

“The wearable devices being developed through this collaboration can be manufactured at scale on Gen2.5 production lines, similar to those on which we have already developed and proven our processes at the Industrial Technology Research Institute (ITRI) in Taiwan, making this an ideal commercial application of our “chip-first” approach in the wearables market. The global wearable technology market is already significant and is projected to more than double from approximately $84 billion today to nearly $186 billion by 2030, growing at a CAGR of 13.6%1.”

Under the agreement, Smartkem will work with its global consumer electronics partner to design and develop a MicroLED display architecture optimized for smart wearables that interface with smart phones, leveraging Smartkem’s OTFT technology to enable thin, flexible and power-efficient backplanes compatible with scalable manufacturing processes. The project is expected to run over a 12-month period, culminating in a proof-of-concept demonstration.

NEWS

Smartkem Signs Letter of Intent with Carbonium Core, Inc. to Expand Advanced Materials Portfolio into Nuclear-Grade Graphite

3 hours ago

Smartkem Signs Proof of Concept Agreement with Global Consumer Electronics Giant for MicroLED Wearables

Jan 6, 2026

Smartkem Signs Proof of Concept Agreement with Global Consumer Electronics Giant for MicroLED Wearables

Jan 6, 2026

Smartkem Unlocks New Generation of Flexible Biometrics with World-First All-Organic Sensor

Dec 10, 2025

Smartkem to Present Disruptive MicroLED Technology at IDW Japan 2025

Dec 1, 2025

Jericho Energy and Smartkem Extend LOI for Proposed All-Stock Merger to Form a U.S.-Owned, Nasdaq-Listed AI Infrastructure Company

Nov 20, 2025

Smartkem and Jericho Energy Ventures Extend Letter Of Intent for Proposed All-Stock Merger to Form U.S.-Owned, AI-Focused Infrastructure Company

Nov 20, 2025

Smartkem Reports Third Quarter 2025 Financial Results

Nov 13, 2025

Smartkem to Exhibit and Present at TechBlick Berlin: The Future of Electronics RESHAPED 2025

Oct 15, 2025

Jericho Energy Ventures and Smartkem Sign Letter of Intent to Create U.S.-Owned, Nasdaq-Listed AI-Focused Infrastructure Company

Oct 7, 2025

Smartkem and Jericho Energy Ventures Sign Letter Of Intent to Create U.S.-Owned, AI-Focused Infrastructure Company

Oct 7, 2025

Smartkem’s CTO Dr. Simon Ogier to Present at MicroLED Connect 2025 in Eindhoven

Sep 23, 2025

Smartkem to Participate at the PlayNitride 2025 MicroLED Technology Forum and Exhibit at SEMICON® Taiwan 2025

Sep 4, 2025

Smartkem Engages Anthony Amato to Support Specific Strategic Initiatives

Sep 2, 2025

Smartkem to Consider Strategic Alternatives

Aug 28, 2025

Smartkem to Deliver Feature Presentations at the 25th International Meeting on Information Display (IMID) in Busan, Korea

Aug 13, 2025

Smartkem Reports Second Quarter 2025 Financial Results

Aug 12, 2025

Smartkem Announces Preliminary Joint Development Agreement with Manz Asia for Advanced Computer and AI Chip Packaging Solutions

Jul 9, 2025

Smartkem Expands Extensive IP Portfolio with New MicroLED Display Manufacturing Patent

Jun 23, 2025

‍

‍

MANAGEMENT

Ian Jenks

Chairman and Chief Executive Officer

Ian has more than 30 years of board-level experience in the industrial technology industry and has served as chief executive officer of companies operating in the United States and Europe. Ian was formerly the president of Uniphase Inc, Chairman of Oplink Communications Inc which he took public on the NASDAQ and spent seven years as a partner of Crescendo Ventures llp. Ian founded and since August 2010 has acted as the CEO of Ian Jenks Limited, a consulting company providing consulting services to companies in the industrial technology industry. Ian has been a director of Techstep ASA, a provider of managed mobile services in the Nordics, Paysafe plc., an international provider of payment processing services, and Brady plc, a provider of commodity trading software. He also has served and continues to serve as a director of a number of private companies. Ian received a B.Sc. in Aeronautical Engineering from Bristol University.

Beverley Brown

Chief Scientist

Prior to joining Smartkem, Beverley held a number of research and development positions in the technology field of advanced materials at Imperial Chemical Industries Ltd. (“ICI”), Zeneca Group PLC and at the Avecia Group PLC. She formed BAB Consultants Ltd in 2006 and for approximately eight years provided consulting services to a number of chemical companies, as well as to the UK government and to the UK’s Centre for Process Innovation, CPI. Beverley has worked in the field of organic semiconductor technology and in printable electronics for almost 20 years. Beverley holds a Ph.D. in Organic Chemistry from the University of Glasgow.

Barbra Keck

Director and Chief Financial Officer

Barbra Keck was formerly the Chief Financial Officer of Deverra Therapeutics, Inc., a developer of cell therapies. Prior to that, she held positions of increasing responsibility at Delcath Systems, Inc., a Nasdaq-listed interventional oncology company, starting as Controller in 2009 and ultimately becoming chief financial officer in February 2017, a position which she held until 2020.

Simon Ogier

Chief Technology Officer

Simon joined Smartkem as CTO in 2019 and is an internationally recognized expert in the field of organic thin-film transistors. Since 2001 he has worked to develop high performance organic semiconductors for transistor applications within companies such as Avecia, Merck, CPI and more recently with NeuDrive Limited. From 2007 whilst at CPI Simon had a major role in establishing the UK’s National Printable Electronics Centre (PETEC), housing a range of state-of-the-art fabrication equipment for pilot scale production of plastic electronic devices. The facility includes £35m of capital equipment capable of processing substrates up to 370 x 470mm in size. He currently manages a team of 19 engineers and scientists using the equipment for Smartkem’s process development and prototype fabrication. Simon has co-authored 30 journal articles and has been co-inventor on 16 patent families. He serves as the project leader for the standard IEC62899-203 “Semiconductor ink” within IEC TC119 WG2 (Printed Electronics – Materials) and has previously participated in IEEE standards for the organic transistor measurement.‍

Jonathan Watkins

Chief Operating Officer

Jonathan Watkins has over 30 years’ experience commercialising and scaling novel material technologies and working across large multinational companies. He has played pivotal roles in managing complex technical product portfolios and developing global supply chains.

SINCERELY,

DISCLAIMER

THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.

OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF FIFTEEN THOUSAND USD BY PRIMETIME PROFILES LLC FOR A ONE DAY SMTK AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.